aspirin has been researched along with dalteparin in 324 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 27 (8.33) | 18.2507 |
| 2000's | 144 (44.44) | 29.6817 |
| 2010's | 113 (34.88) | 24.3611 |
| 2020's | 40 (12.35) | 2.80 |
| Authors | Studies |
|---|---|
| Aguejouf, O; Doutremepuich, C; Doutremepuich, F; Imbault, P; Oualane, FA | 1 |
| Arnout, J; Collen, D; Dol, F; Herbert, JM; Jun, L; Lormeau, JC; Van de Werf, F; Vanhove, P | 1 |
| Arnout, J; Spitz, B; Van Assche, A; Vanrusselt, M; Vermylen, J; Wittevrongel, C | 1 |
| Faunø, P; Husted, SE; Petersen, KD | 1 |
| Branzi, A; Candiotti, N; Cervi, V; Magnani, B; Melandri, G; Palazzini, E; Semprini, F | 1 |
| Bloom, JM | 1 |
| Elikowski, W; Jazienicki, B; Lewandowski, K; Przybył, L; Przybył, M; Psuja, P; Wendland, M; Wróblewski, D; Zawilska, K | 1 |
| Ray, J | 1 |
| Kher, A; Samama, MM | 1 |
| Buchwald, A; Hillis, SE; Klein, W; Ludwig, K; Monrad, S; Olaisson, E; Sanz, G; Turpie, AG; Undeland, S; van der Meer, J | 1 |
| Bigonzi, F; Califf, RM; Cohen, M; Demers, C; Fox, KA; Fromell, GJ; Goodman, S; Gurfinkel, EP; Langer, A; Premmereur, J; Turpie, AG | 2 |
| Swahn, E; Wallentin, L | 1 |
| Bentley, R; Bostwick, JS; Dunwiddie, CT; Kasiewski, CJ; Leadley, RJ; McVey, MJ; Perrone, MH; White, FJ | 1 |
| Piazza, V; Rulli, F | 1 |
| Achenbach, S; Gehling, H; Giannadakis, K; Gotzen, L; Hessmann, M; Lefering, R | 1 |
| Jagodziński, K; Kiwerski, JE; Krasuski, M; Krzyzosiak, L | 1 |
| Zidar, JP | 1 |
| Aguejouf, O; Belougne Malfatti, E; Doutremepuich, C; Doutremepuich, F | 1 |
| Farrell, TP; Hayes, KB; Schneider, DJ; Sobel, BE | 1 |
| Cohen, M; Montalescot, G | 1 |
| Ferguson, JJ | 1 |
| Turpie, AG | 1 |
| Brener, SJ | 1 |
| Creekmore, F | 1 |
| Wallentin, L | 1 |
| Husted, SE | 1 |
| Ben-Ami, M; Brenner, B; Haddad, S; Lanir, N; Ohel, G; Younis, JS | 1 |
| Abdelnoor, M; Berge, E; Nakstad, PH; Sandset, PM | 1 |
| Kobza, II | 1 |
| Blumenfeld, Z; Brenner, B; Hoffman, R; Weiner, Z; Younis, JS | 1 |
| Califf, RM; Cohen, M; Fox, KA; Fromell, GJ; Goodman, SG; Gurfinkel, EP; Stinnett, SS; Weatherley, BD | 1 |
| Bozovich, GE; Gurfinkel, EP; Mautner, B; Quispe, A; Santopinto, J; Strinna, A | 1 |
| Pereira, AC; Warburton, E | 1 |
| Coyne, K; Hammond, M; Lundergan, CF; Ross, AM | 1 |
| Ankri, A; Choussat, R; Collet, JP; Drobinski, G; Lison, L; Montalescot, G; Perlemuter, K; Philippe, F; Thomas, D; Vicaut, E | 1 |
| Buszman, P; Deutsch, E; Gaszewska, E; Kiesz, RS; Kosmider, M; Martin, JL; Rewicki, M; Rozek, MM; Seweryniak, P; Tendera, M | 1 |
| Borja, J; Olivella, P | 1 |
| Cosnard, G; Dechambre, S; Duprez, T | 1 |
| Antman, EM; Bozovich, GE; Gurfinkel, EP; Marcos, E; Mautner, B; McCabe, CH; Santopinto, J; Torres, V | 1 |
| Bigonzi, F; Coyne, K; de Jong, E; Draoui, Y; Knudtson, M; Le Louer, V; Lundergan, C; Molhoek, P; Regalado, L; Ross, AM; Schwartz, W | 1 |
| Hankey, GJ | 1 |
| Bath, PM; Boysen, G; De Deyn, P; Friis, P; Leys, D; Lindenstrom, E; Marttila, R; O'Neill, D; Olsson, J; Orgogozo, J; Ringelstein, B; Turpie, AG; van der Sande, J | 1 |
| McCowan, LM; North, RA; Raudkivi, PJ; Rowan, JA | 1 |
| Batchelor, WB; Berger, PB; Binanay, CA; Deutsch, E; Fry, ET; Hasselblad, V; Mahaffey, KW; Meier, S; Ross, AM; Teirstein, PS; Zidar, JP | 1 |
| Masson, C | 1 |
| Dulitzki, M; Kenett, R; Langevitz, P; Livneh, A; Many, A; Pauzner, R | 1 |
| Barragan, P; Botosezzy, I; Bouvier, JL; Comet, B; Commeau, P; Macaluso, G; Roquebert, PO; Teuma, X | 1 |
| Corry, RJ; Fung, JJ; Jain, A; Johnston, J; Jordan, ML; McCauley, J; Rose, ML; Scantlebury, VP; Shapiro, R; Shullo, MA; Vivas, C | 1 |
| Chamorro, A | 1 |
| Adams, HP | 1 |
| Balducchi, JP; Gris, JC; Hoffet, M; Marès, P; Quéré, I | 1 |
| Bertolet, BD; Gupta, A; Miller, L | 1 |
| Bounameaux, H; Sarasin, FP | 1 |
| Cruickshank, MK; Massel, D | 1 |
| Antman, EM; Ball, SP; Becker, RC; Gibson, M; Murphy, SA; Rush, JE; Sanderink, G; Spencer, FA | 1 |
| Verheugt, FW | 1 |
| Brancaccio, V; Colaizzo, D; Di Minno, G; Grandone, E; Margaglione, M; Pavone, G; Sciannamé, N | 1 |
| Bigonzi, F; Borzak, S; Cohen, M; Frey, MJ; Harris, K; Lis, J; Mukherjee, R; Senatore, F; Théroux, P; Van Mieghem, W; White, HD | 1 |
| Badimon, JJ; Chen, J; Fuster, V; Kunitada, S; Osende, J; Robbins, J; Shimbo, D; Shimoto, Y | 1 |
| Alam, M; Goldberg, LH | 1 |
| Alfar, H; Bick, RL; Goedecke, C | 1 |
| Armstrong, PW; Fitchett, D; Goodman, SG; Langer, A; Tan, M | 1 |
| Ankri, A; Choussat, R; Collet, JP; Dalby, M; Dumaine, R; Fine, E; Golmard, JL; Lesty, C; Montalescot, G; Thomas, D; Vignolles, N | 1 |
| Hunt, BJ; Khamashta, MA; Parmar, K; Poston, L; Seed, PT; Stone, S | 1 |
| Bath, PM | 1 |
| Keays, AC; Keays, SL; Mason, M; Newcombe, PA | 1 |
| Bergstrand, L; Dellborg, M; Fellenius, C; Granger, CB; Lindahl, B; Lins, LE; Nilsson, T; Pehrsson, K; Siegbahn, A; Swahn, E; Wallentin, L | 1 |
| Driscoll, EM; Giboulot, TA; Hong, TT; Lucchesi, BR; Sherigill, A; White, AJ | 1 |
| Balcerzak, A; Breborowicz, GH; Kubiaczyk-Paluch, B; Lewandowski, K | 1 |
| Bigonzi, F; Cohen, M; Danchin, N; Gensini, GF; Gurfinkel, EP; Hecquet, C; Huber, K; Krzeminska-Pakula, M; Maritz, F; Santopinto, J; Timerman, A; Vittori, L; White, HD | 1 |
| Roy, AK; Sarma, GR | 1 |
| Bar, J; Blickstein, D; Hod, M | 1 |
| Cârstocea, B; Gafencu, O; Paiu, M | 1 |
| Adgey, AA; Manoharan, G | 1 |
| Bal dit Sollier, C; Choussat, R; Collet, JP; Dalby, M; Drobinski, G; Drouet, L; Gallois, V; Montalescot, G; Soulat, T; Thomas, D; Vicaut, E | 1 |
| Cochery-Nouvellon, E; Dauzat, M; Gris, JC; Hoffet, M; Lavigne-Lissalde, G; Marès, P; Mercier, E; Quéré, I; Ripart-Neveu, S; Tailland, ML | 1 |
| Schneider, DJ; Sobel, BE; Whitaker, DA | 1 |
| Calvo-Romero, JM | 1 |
| Adgey, JA; Alexander, JH; Armstrong, P; Belmans, A; Bogaerts, K; Diaz, R; Granger, CB; Sinnaeve, PR; Soares-Piegas, L; Tendera, M; Vahanian, A; Van De Werf, FJ; Wallentin, L | 1 |
| Genest, M; Pochmalicki, G | 1 |
| Ardissino, D; Bilheimer, DW; Blazing, MA; Braunwald, E; Califf, RM; de Lemos, JA; DiBattiste, PM; Fox, KA; Gardner, LH; Hasselblad, V; Lewis, EF; Palmisano, J; Pfeffer, MA; Ramsey, KE; Snapinn, SM; Verheugt, FW; White, HD | 1 |
| Alijotas-Reig, J; Ferrer-Raventos, JC | 1 |
| Ballem, PJ; Ensom, MH; Ensworth, S; Houlihan, E; Purkiss, S; Stephenson, MD; Tsang, P | 1 |
| Anderson, DR; Bates, SM; Desjardins, L; Douketis, J; Kahn, SR; Kearon, C; Kovacs, MJ; Rodger, M; Solymoss, S; Turpie, AG; Wells, PS | 1 |
| Ezekowitz, MD | 1 |
| Bilheimer, DW; Blazing, MA; Brady, WE; Braunwald, E; Califf, RM; de Lemos, JA; Fox, KA; Lewis, EF; Palmisano, J; Pfeffer, M; Ramsey, KE; White, HD; Wiviott, SD | 1 |
| Kapilevich, NA; Kisteneva, IV; Markov, VA; Novitskiĭ, VV; Poponina, TM | 1 |
| Armstrong, PW; Welsh, RC | 1 |
| Galileeva, AN; Gritsenko, VV; Kadinskaia, MI; Mochalov, OIu; Orlovskiĭ, PI; Petrishina, TI; Polezhaev, DA; Vavilova, TV | 1 |
| Heptinstall, S; May, JA; Storey, RF | 1 |
| Gonzalez-Ordonez, AJ; Macías-Robles, MD; Peliz, MG | 1 |
| Huxtable, LM; Ondreyco, SM; Tafreshi, MJ | 1 |
| Bartuś, S; Chyrchel, M; Dubiel, JS; Dudek, D; Legutko, J; Rzeszutko, L | 1 |
| James, SK; Johnston, N; Lindbäck, J; Oldgren, J; Siegbahn, A; Wallentin, L | 1 |
| Clemmensen, P; Grande, P; Holmvang, L; Lagerqvist, B; Lindahl, B; Maynard, C; Ripa, RS; Sejersten, M; Wagner, GS; Wallentin, L | 1 |
| Ferguson, JJ; Mahaffey, KW | 1 |
| Averkov, OV; Gratsianskiĭ, NA; Slavina, NN | 1 |
| Hamdan, K; Rajagopal, AS; Shinkfield, M; Voight, S | 1 |
| Daykin, HJ; Jones, C; Sturgeon, SA; Wright, CE | 1 |
| Armstrong, PW; Fitchett, DH; Goodman, SG; Langer, A; Mendelsohn, A; Tan, M | 1 |
| Chouchane, S; Mahjoub, T; Monastiri, K; Samama, MM; Seket, B | 1 |
| Bajraktari, G; Beqiri, A; Berisha, I; Elezi, S; Kastrati, S; Manaj, R; Thaqi, S | 1 |
| Barutcu, I; Boztosun, B; Gunes, Y; Kirma, C | 1 |
| Gelfer, Y; Halperin, N; Oron, A; Peer, A; Robinson, D; Tavor, H | 1 |
| Choi, L; Crowell, MD; Jones, MP; Kaplan, M; Keshavarzian, A; Lau, C; Sharp, L; Wessinger, S; Williams, M | 1 |
| Lindqvist, PG; Merlo, J | 1 |
| Armstrong, PW; Buller, CE; Gallo, R; O'Neill, BJ; Pate, GE; Webb, JG; Welsh, RC | 1 |
| Armstrong, PW | 1 |
| Brenner, B; Carp, H; Dolitzky, M; Inbal, A; Segal, Y; Weiss, A | 1 |
| Boccadoro, M; Palumbo, A; Rodeghiero, F; Rus, C; Zeldis, JB | 1 |
| Bottner, F; Haas, SB; Laskin, RS; Sculco, TP; Westrich, GH; Windsor, RE | 1 |
| Arntz, HR; Darius, H; Huber, K; Senges, J; Zeymer, U | 1 |
| Amann-Vesti, BR; Banyai, M; Koppensteiner, R; Meier, T; Pfammatter, T; Rousson, V; Spring, S; van der Loo, B | 1 |
| Liu, GY; Wang, XK; Wang, Y; Yang, CM; Zhang, Y | 1 |
| Bhatt, DL; Cannon, CP | 1 |
| Athanasian, EA; Dreese, JC; Flik, KR; Gardner, MJ; Lyden, JP | 1 |
| Assy, N; Hussein, O; Khalil, A; Luder, A; Paizi, M; Spira, G; Szvalb, S | 1 |
| Chen, C; Fong, WC; Gao, H; Li, HL; Ng, PW; Tsoi, TH; Wong, CK; Wong, HB; Wong, KS; Yeung, J; Yip, KK | 1 |
| Aharonoff, GB; Egol, KA; Gruson, KI; Jeong, GK; Karp, AH; Koval, KJ; Zuckerman, JD | 1 |
| Ammar, AD; Woolard, JD | 1 |
| Agnelli, G; Andersson, M; Bylock, A; Cohen, AT; Dahl, OE; Eriksson, BI; Mouret, P; Ogren, M; Panfilov, S; Rosencher, N | 1 |
| Bath, PM; Boysen, G; De Deyn, PP; Gray, LJ; Leys, D; O'Neill, D; Ringelstein, EB; Sprigg, N | 1 |
| David, M; Dubois, E; Leduc, L; Rey, E; Takser, L | 1 |
| Christopoulou-Cokkinou, V; Creatsas, G; Dendrinos, S; Kalogirou, I; Mahmound, EA; Makrakis, E; Theodoridis, T | 1 |
| Davis, KE; Denardo, SJ; Tcheng, JE | 1 |
| Owen, A | 1 |
| Ertem, K | 1 |
| Antman, EM; Braunwald, E; Budaj, A; Guneri, S; Jacob, AJ; Morrow, DA; Murphy, SA; Qin, J; Ruda, M | 1 |
| Boutary, M; Dorr, LD; Gendelman, V; Long, WT; Maheshwari, AV; Wan, Z | 1 |
| El-Refaiey, AA; El-Tatongy, M; Fawzy, M; Mosbah, A; Shokeir, T; Warda, O | 1 |
| Chang, CM; Chu, WM; Lam, KF; Lau, YK; Ng, FH; Wong, BC; Wong, SY | 1 |
| Bick, RL | 1 |
| Farahvash, MS; Moghaddam, MM; Moghimi, S; Mohammadzadeh, S | 1 |
| Kwa, AT; Rogers, JH | 1 |
| Chauleur, C; Decousus, H; Laporte, S; Mismetti, P; Quenet, S; Seffert, P; Varlet, MN | 1 |
| Beilin, O; Blank, M; Chapman, J; Grigoriadis, NC; Katzav, A; Landenberg, Pv; Pick, CG; Shoenfeld, Y; Tanne, D | 1 |
| Smoot, EC | 1 |
| Alvarez-Blanco, M; Fernández Rogríguez, S; Fernández-Meré, LA | 1 |
| Creemers, E; Grayet, B; Hans, GA; Lamy, ML; Ledoux, D; Scholtes, F; Senard, M | 1 |
| Farahvash, MM; Farahvash, MS; Mirshahi, A; Mohammadzadeh, S; Moradimogadam, M | 1 |
| Fishmann, A | 1 |
| Braun-Dullaeus, RC; Hass, N; Ibrahim, K; Kolschmann, S; Strasser, RH | 1 |
| Antman, EM; Aylward, PE; Bergovec, M; Buros, JL; Col, JJ; Gibson, CM; Goodman, SG; Gulba, D; Kunadian, V; Murphy, SA; Pride, YB; Zorkun, C | 1 |
| Eddington, ND; Khurana, M; Myers, AL; Upreti, VV | 1 |
| Farahvash, MM; Farahvash, MS; Mohammadzadeh, S; Moradimogadam, M | 1 |
| Alijotas-Reig, J; Cabero-Roura, L; Casellas-Caro, M; Ferrer-Oliveras, R; Hermosilla, E; Llurba-Olive, E; Vilardell-Tarres, M | 1 |
| Dolgikh, VT; Faĭl', IL; Kireeva, NV; Kovaleva, SV; Morova, NA; Smirnov, DE | 1 |
| Buerke, M; Carter, JM; Hauroeder, B; Maegdefessel, L; Michel, T; Peetz, D; Reindl, I; Schlitt, A; Schubert, S; Werdan, K | 1 |
| Eckstein, HH; Grau, C; Stammler, F | 1 |
| Garcia-Rinaldi, RF; Macdonald, RJ; McKellar, SH; Schaff, HV; Sundt, TM; Thompson, JL | 1 |
| Rajek, A; Sandner, SE; Schima, H; Steinlechner, B; Wieselthaler, GM; Wolner, E; Zimpfer, D; Zrunek, P | 1 |
| Alberico, S; Bernardon, M; Businelli, C; Limone, A; Maso, GP; Piccoli, M | 1 |
| Bath, PM; Christensen, H; De Deyn, PP; England, T; Geeganage, C; Gray, LJ; Leys, D; Moulin, T; O'Neill, D; Ringelstein, EB; Sare, GM; Woimant, F | 1 |
| Wu, WD; Zhang, H | 1 |
| Bauer, T; Gitt, AK; Heer, T; Juenger, C; Senges, J; Towae, F; Zahn, R; Zeymer, U | 1 |
| Aydog, ST; Demirel, H; Dönmez, G; Doral, MN; Ozçakar, L; Pasaoglu, I; Yörübulut, M | 1 |
| Balletshofer, B; Henes, J; Oberländer, Y; Schneider, W; Tepe, G | 1 |
| Goodall, AH; Hayes, PD; Jones, CI; McMahon, GS; Naylor, AR; Webster, SE | 1 |
| Kremer, S; Kuntzmann, H; Laalou, FZ; Mahoudeau, G; Pain, L | 1 |
| Egurbide, MV; Martinez-Berriotxoa, A; Ruiz-Irastorza, G | 1 |
| Mehta, AV; Teixeira, OH | 1 |
| Ageno, W; Campana, F; Cattaneo, R; Chelazzi, P; Cimino, L; D'Angelo, S; Filippucci, E; Ghirarduzzi, A; Imberti, D; Incorvaia, C; Manfredi, E; Molfino, F; Ricci, AL; Romanelli, D; Rubbi, F; Scannapieco, G; Venco, L | 1 |
| Gibson, CM; Hollander, JE; Pollack, CV | 1 |
| Eberli, FR; Roffi, M | 1 |
| Apter, S; Dulitzky, M; Salomon, O | 1 |
| Cipil, HS; Ercetin, S; Firat, HC; Goker, H; Haznedaroglu, IC; Kaya, A; Kirazli, S; Kosar, A; Ozdemir, O; Uz, B | 1 |
| Baumgarten, S; Dörner, T; Kadecki, O; Kiesewetter, H; Monien, S; Salama, A | 1 |
| Li, TC; Makris, M; Metwally, M; Mo, D; Saravelos, S | 1 |
| Smalligan, R; Valdez, G | 1 |
| Damman, P; de Winter, RJ; Hirsch, A; Tijssen, JG; Windhausen, F | 1 |
| Bremerich, J; Christ, M; Wandeler-Meyer, K | 1 |
| Davies, SR; Goldszmidt, E; Kasodekar, SV | 1 |
| Dönmez, O; Durmaz, O | 1 |
| Brennan, MT; Furney, SL; Hong, CH; Lockhart, PB; Napeñas, JJ | 1 |
| Clark, P; Crichton, L; Greaves, M; Greer, IA; Langhorne, P; Thomson, A; Walker, ID; Whyte, S | 1 |
| Büller, HR; Folkeringa, N; Goddijn, M; Hamulyák, K; Hutten, BA; Kaandorp, SP; Middeldorp, S; Mol, BW; Nahuis, M; Papatsonis, DN; van der Post, JA; van der Veen, F; Verhoeve, HR | 1 |
| Greer, IA | 1 |
| Gasse, N; Loisel, F; Meresse, T; Obert, L; Pauchot, J; Rochet, S; Tropet, Y | 1 |
| Armstrong, PW; Bluhmki, E; Danays, T; Gershlick, A; Goldstein, P; Van de Werf, F; Wilcox, R | 1 |
| Bett, N; Chua, R; Hunt, B | 1 |
| Aïssaoui, N; Danchin, N | 1 |
| Basak, S; Bhattacharya, R; Das Baksi, S; Dutta, D; Gangopadhyay, S; Pani, A; Sarkar, RN | 1 |
| Luo, B; Pan, J; Sun, L; Wang, J; Xia, Q; Xu, L | 1 |
| Calık, AN; Demirci, D; Güvenç, TS; Ilhan, E | 1 |
| Bath, PM; Christensen, H; De Deyn, P; England, TJ; Geeganage, C; Leys, D; Moulin, T; O'Neill, D; Ringelstein, EB; Sare, GM; Woimant, F | 1 |
| Bloemenkamp, KW; Helmerhorst, FM; Kaaja, RJ; Lampinen, K; Morin-Papunen, L; Ulander, VM; Visser, J | 1 |
| Cano, O; Castro, JE; Olagüe, J; Osca, J; Salvador, A; Sancho-Tello, MJ | 1 |
| Abdou, AM; Fouda, IM; Fouda, UM; Ramadan, DI; Sayed, AM; Zaki, MM | 1 |
| Huang, L; Kanellis, J; Mulley, W | 1 |
| Baldini, L; Benevolo, G; Boccadoro, M; Bringhen, S; Callea, V; Caravita, T; Carella, AM; Cavo, M; Cellini, C; Crippa, C; Elice, F; Evangelista, A; Galli, M; Gentilini, F; Magarotto, V; Marasca, R; Montefusco, V; Morabito, F; Nozzoli, C; Offidani, M; Palumbo, A; Patriarca, F; Pescosta, N; Polloni, C; Pulini, S; Ria, R; Romano, A; Rossi, D; Tacchetti, P; Tosi, P; Zamagni, E; Zambello, R | 1 |
| Bath, PM; Christensen, H; De Deyn, PP; Gray, LJ; Leys, D; O'Neill, D; Ringelstein, EB; Sprigg, N | 1 |
| Beggiato, E; Boccadoro, M; Bringhen, S; Cafro, AM; Carella, AM; Catalano, L; Cavalli, M; Cavallo, F; Cavo, M; Corradini, P; Crippa, C; Di Raimondo, F; Di Toritto, TC; Evangelista, A; Falanga, A; Larocca, A; Nagler, A; Palumbo, A; Patriarca, F; Peccatori, J; Petrucci, MT; Pezzatti, S; Siniscalchi, A; Stanevsky, A; Yehuda, DB | 1 |
| Alalaf, S | 1 |
| Assadian, A; Bergmayr, W; Duschek, N; Hirsch, K; Hübl, W; Knoebl, P; Skrinjar, E; Vafaie, M; Waldhör, T | 1 |
| Braun, J; Koppensteiner, R; van der Loo, B | 1 |
| Chauleur, C; Dauzat, M; Fabbro-Peray, P; Gris, JC; Haddad, B; Lefrant, JY; Marès, P; Molinari, N; Quéré, I | 1 |
| Giazitzoglou, E; Katritsis, DG; Korovesis, S; Meier, B; Tzanalaridou, E; Zografos, T | 1 |
| Bang, OY; Kim, JS | 1 |
| Chen, C; Chen, XY; Han, JH; Leung, TW; Mok, V; Soo, Y; Wang, QS; Wong, KS | 1 |
| Chan, K; Chu, WM; Keung, KK; Kng, C; Kwan, A; Lam, KF; Lau, YK; Li, A; Ng, FH; Tunggal, P; Wong, BC | 1 |
| Dahl, OE; Eriksson, BI; Friedman, RJ; Homering, M; Rosencher, N | 1 |
| Anderson, BJ; Bradbury, TL; Erens, GA; Hamilton, SC; Roberson, JR; Whang, WW | 1 |
| Amin, AG; Hsu, W; Lim, M; Ng, J; Pradilla, G; Quinones-Hinojosa, A; Raza, S | 1 |
| Appenzeller, S; Costallat, LT; Mahayri, N; Nadruz, W; Velho, P; Yazbek, MA | 1 |
| DeSimone, LJ; Gillette, BP; Pagnano, MW; Sierra, RJ; Trousdale, RT | 1 |
| Carroll, PR; Chan, JM; Choe, KS; Cowan, JE; D'Amico, AV; Liauw, SL | 1 |
| Alexander, M; Kirsa, S; Lingaratnam, S; Mellor, JD; Teoh, KC | 1 |
| Coste, P; Gerbaud, E; Seguy, B | 1 |
| Cossetto, DJ; Goudar, A; Parkinson, K | 1 |
| Bacci, MR; Namura, JJ; Nogueira, LF; Santos, JA | 1 |
| Goodall, AH; Hayes, PD; Jones, CI; McMahon, GS; Naylor, AR | 1 |
| Alfonso, F; Bañuelos, C; Echavarría-Pinto, M; Escaned, J; Fernández, C; Fernandez-Ortiz, A; García, E; Gonzalo, N; Gorgadze, T; Hernández, R; Ibañez, B; Jiménez-Quevedo, P; Lopes, R; Macaya, C; Nuñez-Gil, IJ | 1 |
| Eley, KA; Parker, RJ; Watt-Smith, SR | 1 |
| Anderson, DR; Andreou, P; Belzile, E; Bohm, ER; Carrier, M; Crowther, M; Davis, N; Dunbar, MJ; Fisher, W; Gofton, W; Gross, P; Kahn, SR; Kim, P; Kovacs, M; MacDonald, S; Pelet, S; Pleasance, S; Ramsay, T; Rodger, MA; Vendittoli, PA; Wells, P; Zukor, D | 1 |
| Aziz Mohammadi, M; Debeij, J; Enajat, M; Mureau, MA; van der Hulst, RR | 1 |
| Steinberg, DI | 1 |
| Cohen, AT; Granziera, S | 1 |
| Anderson, DR; Dunbar, MJ; Kahn, SR | 1 |
| Dugdale, M; Fabian, TC; Gordon, JL; Lee, MD | 1 |
| Markun, S | 1 |
| Adam, I; Ashur, BM; Elbareg, AM; Elmahashi, MO; Essadi, FM | 1 |
| Gupta, K; Singh, D; Vacek, JL | 1 |
| Loidi Pascual, L; Valcayo Peñalba, A; Yanguas Bayona, I; Yerani Ruiz de Azúa Ciria, A | 1 |
| Chi, W; Lin, J; Wang, C; Yi, X; Zhang, B | 1 |
| Brighton, TA; Davidson, BL; Gebel, M; Lensing, AW; Lyons, RM; Prins, MH; Rehm, J; Verheijen, S | 1 |
| Chen, GX; Han, CM; Pan, XL; Shao, HW; Zhang, LP; Zhi, LZ | 1 |
| Darashchonak, N; Erlenwein, SV; Kleppa, MJ; von Kaisenberg, CS; von Versen-Höynck, F | 1 |
| Aljaser, F; Campbell, BK; Fisher, J; Hernandez-Medrano, J; McNeilly, AS; Onions, V; Picton, HM; Pincott-Allen, C; Webb, R | 1 |
| de Jong, PG; Di Nisio, M; Goddijn, M; Kaandorp, S; Middeldorp, S | 1 |
| Connors, JM | 1 |
| Coban, G; Horasanlı, B; Karalezli, A; Yeşilırmak, N | 1 |
| Anderson, JL; Bates, ER; Bode, C; Granger, CB; Huber, K; Kristensen, SD; Lopez Sendon, JL; Ohman, EM; Steg, PG; Tubaro, M; Valgimigli, M; Wallentin, L | 1 |
| Bley, TA; Gassenmaier, T; Goltz, JP; Klein, D; Kunz, AS; Petritsch, B; Sauer, S | 1 |
| Calıskan, A; Demirtas, S; Guclu, O; Kaplan, I; Karahan, O; Tezcan, O; Yavuz, C; Yazıcı, S | 1 |
| Langialonga, T; Maggi, A; Martimucci, M; Mele, M; Villella, A; Villella, M | 1 |
| Fletcher, J; Gruen, R; Koh, TL; Ong, WL; Royce, P | 1 |
| Dobbs, B; Mercer, S; Tian, PG; Triscott, J | 1 |
| Assad, M; Billotte, C; Coffin-Pichonnet, S; Denion, É | 1 |
| Cho, KJ; Fang, R; Kim, TK; Kim, YH; Na, YG | 1 |
| Beattie, GW; Chello, M; Lusini, M; Nappi, F; Nenna, A; Petitti, T; Prestipino, F; Spadaccio, C; Sutherland, FW | 1 |
| Bochenek, A; Buldak, Ł; Buszman, P; Kondys, M; Milewski, K; Sanak, M; Wilczynski, M; Wita, K; Wybraniec, MT | 1 |
| Abdelmeged, AN; Abu-Elghar, MM; Abu-Elhasan, AM; Hamed, AH; Ismail, AM; Saso, S | 1 |
| Beato, J; Carneiro, Â; Falcão, M; Fígueira, L; Penas, S; Reis, FF; Santos-Silva, R | 1 |
| Barbudo, J; Campos Hernandez, JP; Cazalilla, M; Gomez Gomez, E; Prieto, R; Requena Tapia, MJ; Triviño, F | 1 |
| Bautista, MP; Bonilla, GA | 1 |
| Chan, A; Choong, K; Fulford, M; Nayan, S; Rebelo, J; Sommer, DD | 1 |
| Fahed, E; Ghauche, J; Maarrawi, J; Menassa-Moussa, L; Moussa, R; Nohra, G; Okais, N; Rahme, R; Rizk, T; Samaha, E | 1 |
| Hall, KE; Nakasone, CK; Radzak, KN; Wages, JJ | 1 |
| Laurence, TN; Raheemullah, A | 1 |
| Bages, K; Bastuji-Garin, S; Benachi, A; Bretelle, F; Chauleur, C; Chitrit, Y; Gris, JC; Haddad, B; Houfflin-Debarge, V; Tsatsaris, V; Winer, N | 1 |
| Boettner, F; Mayman, DJ; Pearle, AD; Schmidt-Braekling, T; Waldstein, W; Westrich, GH | 1 |
| Elias, A; Elias, M; Nahas, R; Saliba, W | 1 |
| Bujold, E; Demers, S; Roberge, S | 1 |
| Abdulghani, S; Gruslin, A; Grynspan, D; Moretti, F | 1 |
| Armstrong, PW; Gershlick, A; Halvorsen, S; Huber, K; Shavadia, J; Steg, PG; Van de Werf, F; Welsh, R; Zheng, Y | 1 |
| Amanatullah, DF; Bala, A; Goodman, SB; Huddleston, JI; Maloney, WJ | 1 |
| Bini, SA; Cafri, G; Cheetham, CT; Chen, Y; Gould, MK; Khatod, M; Paxton, EW; Sluggett, J | 1 |
| Whiting, DR | 1 |
| Anastasiadou, C; Galyfos, G; Geropapas, G; Giannakakis, S; Kastrisios, G; Kerasidis, S; Maltezos, C; Papacharalampous, G; Papapetrou, A; Sachmpazidis, I | 1 |
| Chen, X; Jin, Y; Wang, Z; Xiang, Y; Zhao, Y; Zheng, J | 1 |
| Goh, G; Jones, CW; Joseph, Z; Spasojevic, S; Wood, DJ; Yates, PJ | 1 |
| Li, CJ; Liu, DL; Shi, XL; Yang, ZH | 1 |
| Bobrow, D; DeAngelis, LM; DeSancho, MT; Marshall, RS; Navi, BB; Singer, S; Stone, JB | 1 |
| Arsoy, D; Giori, NJ; Woolson, ST | 1 |
| Brewster, A; Burchette, JE; El-Bazouni, H; Lindquist, DE; Odle, BL; Stewart, DW; Waldroup, C | 1 |
| Acar, R; Erturk, I; Ozgurtas, T; Saglam, K; Yesildal, F | 1 |
| Azboy, I; Groff, H; Parvizi, J | 1 |
| Buchmüller, A; Jilma, B; Samaha, E; Schranz, S; Schwameis, M; Watschinger, B | 1 |
| Bawa, H; Dirschl, DR; Luu, HH; Weick, JW | 1 |
| Cipparrone, NE; Goldstein, JM; Goldstein, WM; Pardi, BM; Schwartz, BE; Shah, RR; Woon, CYL | 1 |
| Chen, Y; Cheng, X; Li, N; Lin, T; Sheng, X | 1 |
| Gottschalk, MB; Pour, AE; Roberson, JR; Runner, RP; Staley, CA | 1 |
| Atukorale, Y; Ma, N; Maddern, G; Nadi, S; Rovers, M; Vreugdenburg, TD | 1 |
| Amanatullah, DF; Bala, A; Burk, DR; Goodman, SB; Huddleston, JI; Maloney, WJ; Murasko, MJ | 1 |
| Ben David, C; Carp, H; Solt, I | 1 |
| Butler, S; Harris, IA; Kerr, DL; Read, AC | 1 |
| Beckmann, N; Bercz, A; Goodman, MD; Gulbins, E; Kassam, F; Makley, AT; Morris, MC; Schumacher, F | 1 |
| Harris, IA; Sidhu, V | 1 |
| Huang, Q; Shen, B; Si, HB; Xing, SX; Zeng, Y; Zhou, ZK | 1 |
| Jacobson, B; Leisegang, R; Naidoo, P; Paek, D; Rambiritch, V; Sayre, T; Shan, J | 1 |
| Brodmann, M; Hafner, F; Jud, P | 1 |
| Chambers, HG; Epps, H; Hogue, GD; Murphy, RF; Shore, BJ; Spence, DD; Williams, D | 1 |
| Dishy, V; Kobayashi, F; Kochan, J; Limsakun, T; McPhillips, P; Mendell, J; Orihashi, Y; Pav, J; Pizzagalli, F; Rambaran, C; Vandell, AG; Warren, V; Zhou, J | 1 |
| Boughalem, E; Frere, C; Kubicek, P | 1 |
| Dahly, D; Fleming, A; Kehoe, E; McGrath, B; Ní Cheallaigh, S; O'Byrne, JM; O'Connell, C; Sahm, LJ | 1 |
| Alay, H; Can, FK; Gözgeç, E | 1 |
| An, VVG; Farey, JE; Harris, IA; Karunaratne, S; Sidhu, V | 1 |
| Ali, I; Bazzar, A; Hussein, N; Sahhar, E | 1 |
| Hashmi, J; Lal, S | 1 |
| Castillo, RC; Haac, BE; Manson, TT; O'Hara, NN; O'Toole, RV; Slobogean, GP; Stein, DM | 1 |
| Gao, M; Lei, J | 1 |
| Bouvier, S; Demattei, C; Fortier, M; Gris, JC; Herzog, M; Letouzey, V; Mercier, E; Mousty, E; Nouvellon, E; Rommelaere, G; Vincent, L | 1 |
| Issa, M; Patel, S; Sanborn, D | 1 |
| Fukushima, R; Iwanaga, T; Maruyama, I; Miura, N; Nagasato, T | 1 |
| Cornett, B; Dziadkowiec, O; Harkness, W; Hassan, S; Hicks, ME; Kopstein, M; Scherbak, D; Watts, PJ | 1 |
| Abdelrahman, AG; Abdelwahab, HW; Aiash, H; Amin, H; Darling, E; Elfar, MSA; Fadel, G; Fouad, AM; Merrell, E; Mishriky, A; Nieman, GF; Riley, JB; Sabry, K; Salama, R; Sayed Ahmed, HA; Shah, J; Shaltout, SW | 1 |
| Gorgun, E; Holubar, SD; Hull, TL; Leeds, IL; Lightner, AL; Liska, D; Sklow, B; Steele, SR | 1 |
| Ates, O; Dogan, M; Ersoz, E; Hacioglu Kasim, FB; Karaarslan, N; Ozbek, H; Yilmaz, I | 1 |
| Du, JY; Metcalf, KB; Ochenjele, G | 1 |
| Aynardi, MC; Bonaddio, V; Kirchner, GJ; Koroneos, Z; Lorenz, FJ; Manto, KM; Martinazzi, BJ; Stauch, CM | 1 |
| Ackerman, I; Adie, S; Bastiras, D; Brighton, R; Buchbinder, R; Burns, AWR; Cashman, K; Chong, BH; Clavisi, O; Cripps, M; de Steiger, R; Dekkers, M; Dixon, M; Ellis, A; Graves, SE; Griffith, EC; Hale, D; Hansen, A; Harris, A; Harris, IA; Hau, R; Horsley, M; James, D; Kelly, TL; Khorshid, O; Kuo, L; Lewis, P; Lieu, D; Lorimer, M; MacDessi, S; McCombe, P; McDougall, C; Mulford, J; Naylor, JM; Page, RS; Pratt, N; Radovanovic, J; Sidhu, VS; Solomon, M; Sorial, R; Summersell, P; Tran, P; Walter, WL; Webb, S; Wilson, C; Wysocki, D | 1 |
| Whipple, MO | 1 |
| Garcia, D | 1 |
| Harris, IA; Sidhu, VS | 1 |
| Chen, CH; Hsu, CH; Hsu, NC | 1 |
| Hsu, CC; Hsu, CJ; Wei, JC | 1 |
| DeMik, DE; Dunbar, M; Mont, MA | 1 |
| Adie, S; Harris, IA; Horsley, M; Kim, RG; Lieu, D; Naylor, JM; Sidhu, VS; Walker, R | 1 |
| Ackerman, I; Adie, S; Bastiras, D; Buchbinder, R; Harris, IA; Naylor, JM; Sidhu, V | 1 |
| Almaghaslah, D; Khaled, A; Makki, S; Nagib, R; Siddiqua, A | 1 |
| Chen, F; Fu, G; Ge, L; Huang, L; Jiang, W; Liu, C; Liu, Q; Ouyang, Z; Pan, G; Pan, H; Shen, Q; Xiao, Y; Zeng, G; Zhang, Y; Zheng, Z; Zhou, C; Zhou, S; Zhu, C | 1 |
| Kulkarni, NS | 1 |
| Christ, AB; Heckmann, ND; Kang, HP; Lieberman, JR; Mayfield, CK; Mills, ES; Piple, AS; Wang, JC | 1 |
| Hanke, K; Helm, M; Hossfeld, B; Kulla, M; Lechner, R; Mayer, B; Schmid, A | 1 |
| Griffin, M; Lip, GYH | 1 |
| Ackerman, IN; Adie, S; Bastiras, D; Brighton, R; Buchbinder, R; Burns, AWR; Cashman, K; Chong, BH; Clavisi, O; Cripps, M; de Steiger, R; Dekkers, M; Dixon, M; Ellis, A; Graves, SE; Griffith, EC; Hale, D; Hansen, A; Harris, A; Harris, IA; Hau, R; Horsley, M; James, D; Kelly, TL; Khorshid, O; Kuo, L; Lewis, PL; Lieu, D; Lorimer, M; MacDessi, SJ; McCombe, P; McDougall, C; Mulford, J; Naylor, JM; Page, RS; Pratt, N; Radovanovic, J; Sidhu, VS; Solomon, M; Sorial, R; Summersell, P; Tran, P; Walter, WL; Webb, S; Wilson, C; Wysocki, D | 1 |
| Ebell, MH | 1 |
| Chang, WL; Chen, CF; Chen, WM; Chou, TA; Pai, FY; Tsai, SW; Wu, PK | 1 |
| Conway, S; Pang, N; Rose, M | 1 |
30 review(s) available for aspirin and dalteparin
| Article | Year |
|---|---|
[Low molecular weight heparin in unstable angina].
Topics: Angina, Unstable; Anticoagulants; Aspirin; Dalteparin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Survival Rate; Treatment Outcome | 1996 |
Low molecular weight heparins in the cardiac catheterization laboratory.
Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Cardiac Catheterization; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine; Tunica Intima | 1999 |
Anticoagulants in acute coronary syndromes.
Topics: Acute Disease; Angina, Unstable; Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Disease; Dalteparin; Enoxaparin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Recombinant Proteins | 1999 |
Unfractionated and low-molecular-weight heparins in acute coronary syndromes: current recommendations.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Disease; Enoxaparin; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Monitoring, Physiologic; Myocardial Infarction; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic | 2000 |
Long-term management--the way forward?
Topics: Angina, Unstable; Anticoagulants; Aspirin; Coronary Artery Disease; Dalteparin; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Humans; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2000 |
Targeting treatment for optimal outcome.
Topics: Age Factors; Aged; Angina, Unstable; Anticoagulants; Aspirin; Biomarkers; Clinical Protocols; Dalteparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Risk Factors; Sex Factors; Troponin T | 2000 |
[Low molecular weight heparin in the treatment of acute coronary syndromes without ST-segment elevation: unstable angina and non-Q-wave myocardial infarction].
Topics: Angina, Unstable; Anticoagulants; Aspirin; Clinical Trials as Topic; Confidence Intervals; Dalteparin; Data Interpretation, Statistical; Double-Blind Method; Electrocardiography; Enoxaparin; Female; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Myocardial Infarction; Nadroparin; Odds Ratio; Placebos; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk; Time Factors | 2000 |
[Antithrombotic treatment protocols in interventional cardiology].
Topics: Aspirin; Clopidogrel; Drug Resistance; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Stents; Thrombosis; Ticlopidine | 2001 |
Enoxaparin in acute coronary syndromes: evidence for superiority over placebo or untreated control.
Topics: Anticoagulants; Aspirin; Confidence Intervals; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Odds Ratio; Randomized Controlled Trials as Topic; Syndrome | 2002 |
Current management of unstable angina: lessons from the TACTICS-TIMI 18 trial.
Topics: Angina, Unstable; Angioplasty, Balloon; Aspirin; Dalteparin; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Myocardial Ischemia; Randomized Controlled Trials as Topic; Risk Assessment; Thrombolytic Therapy; Tirofiban; Tyrosine | 2002 |
[Acute coronary syndromes without ST segment elevation].
Topics: Acute Disease; Adrenergic beta-Antagonists; Analgesics, Opioid; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Calcium Channel Blockers; Clopidogrel; Coronary Disease; Electrocardiography; Enoxaparin; Humans; Morphine; Myocardial Revascularization; Oxygen Inhalation Therapy; Patient Selection; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Ticlopidine; Time Factors | 2004 |
A marriage of enhancement: fibrinolysis and conjunctive therapy.
Topics: Animals; Antithrombins; Aspirin; Blood Platelets; Cell Adhesion; Clinical Trials as Topic; Dose-Response Relationship, Drug; Enoxaparin; Fibrinolysis; Fibrinolytic Agents; Glycoproteins; Heparin; Heparin, Low-Molecular-Weight; Humans; Inflammation; Ligands; Models, Biological; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Thrombin; Thrombolytic Therapy | 2004 |
Antiphospholipid syndrome in pregnancy.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Enoxaparin; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications, Hematologic; Thrombophilia | 2008 |
Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antithrombins; Aspirin; Clopidogrel; Enoxaparin; Eptifibatide; Fibrinolytic Agents; Heart Conduction System; Hemorrhage; Heparin; Hirudins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Risk Assessment; Risk Factors; Ticlopidine | 2008 |
[The antiphospholipid syndrome in the 21st century].
Topics: Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Dalteparin; Enoxaparin; Female; Fetal Death; Humans; Lupus Coagulation Inhibitor; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications; Primary Prevention; Retrospective Studies; Risk Factors; Thrombosis; Time Factors | 2009 |
Hospitals with and without percutaneous coronary intervention capability: considerations for treating acute coronary syndromes.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Emergency Service, Hospital; Enoxaparin; Fondaparinux; Health Services Accessibility; Hirudins; Humans; Peptide Fragments; Platelet Aggregation Inhibitors; Polysaccharides; Recombinant Proteins; Ticlopidine; Triage; United States | 2009 |
Diabetes and acute coronary syndromes.
Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Blood Glucose; Clopidogrel; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enoxaparin; Hirudins; Humans; Hypoglycemic Agents; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Recombinant Proteins; Thiophenes; Thrombosis; Ticlopidine | 2009 |
Pharmacologic therapy for non ST-segment elevation acute coronary syndromes: focus on antithrombotic therapy.
Topics: Acute Coronary Syndrome; Adenosine; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Disease Management; Drug Synergism; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Recombinant Proteins; Thiophenes; Ticagrelor; Ticlopidine | 2010 |
Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies.
Topics: Anticoagulants; Aspirin; Benzimidazoles; Clopidogrel; Dabigatran; Emergencies; Enoxaparin; Fondaparinux; Heparin; Humans; Morpholines; Platelet Aggregation Inhibitors; Platelet Transfusion; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Ticlopidine; Warfarin | 2013 |
Anticoagulation and antiplatelet therapy in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Enoxaparin; Fondaparinux; Heparin; Hirudins; Humans; Morpholines; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Ticagrelor; Ticlopidine; Warfarin | 2014 |
Effect of heparin on prevention of flap loss in microsurgical free flap transfer: a meta-analysis.
Topics: Aspirin; Dalteparin; Free Tissue Flaps; Heparin; Humans; Odds Ratio; Retrospective Studies; Treatment Outcome | 2014 |
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Enoxaparin; Female; Heparin, Low-Molecular-Weight; Humans; Live Birth; Nadroparin; Pregnancy; Pregnancy Complications, Hematologic; Randomized Controlled Trials as Topic; Thrombophilia | 2014 |
Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Fondaparinux; Heparin; Hirudins; Humans; Lactones; Peptide Fragments; Peptides; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Pyridines; Receptors, Thrombin; Recombinant Proteins; Thiophenes; Ticagrelor; Tirofiban; Tyrosine; Warfarin | 2014 |
Retroperitoneal haematoma associated with enoxaparin use in an elderly woman with chronic kidney disease.
Topics: Aged, 80 and over; Anticoagulants; Aspirin; Enoxaparin; Erythrocyte Transfusion; Female; Hematoma; Hemorrhage; Humans; Pulmonary Embolism; Radiography, Abdominal; Renal Insufficiency, Chronic; Retroperitoneal Space; Tomography, X-Ray Computed | 2015 |
Effectiveness and Tolerability of Anticoagulants for Thromboprophylaxis after Major Joint Surgery: a Network Meta-Analysis.
Topics: Anticoagulants; Aspirin; Databases, Factual; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Joint Diseases; Odds Ratio; Postoperative Complications; Pyrazoles; Pyridones; Venous Thromboembolism | 2017 |
Enoxaparin (or plus aspirin) for the prevention of recurrent miscarriage: A meta-analysis of randomized controlled studies.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Live Birth; Pre-Eclampsia; Pregnancy; Randomized Controlled Trials as Topic; Research Design | 2019 |
Safety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Australia; Case-Control Studies; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Network Meta-Analysis; Orthopedics; Placebos; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Safety; Treatment Outcome; Venous Thromboembolism | 2019 |
Does the form of venous thromboembolism prophylaxis following primary total knee arthroplasty alter the rate of early reoperation or revision surgery?
Topics: Arthroplasty, Replacement, Knee; Aspirin; Australia; Case-Control Studies; Clinical Decision-Making; Enoxaparin; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Humans; Perioperative Period; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Reoperation; Rivaroxaban; Safety; Treatment Outcome; Venous Thromboembolism | 2019 |
Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis.
Topics: Anticoagulants; Aspirin; Enoxaparin; Female; Hemorrhage; Humans; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Venous Thromboembolism | 2020 |
Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Enoxaparin; Heparin, Low-Molecular-Weight; Humans; Venous Thromboembolism | 2021 |
102 trial(s) available for aspirin and dalteparin
| Article | Year |
|---|---|
Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Aspirin; Coronary Disease; Dalteparin; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence | 1996 |
[Low molecular weight heparin (Fraxiparine) as adjunctive therapy with thrombolysis for acute myocardial infarction: a pilot study with a one year follow up].
Topics: Adult; Aged; Aspirin; Echocardiography; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Nadroparin; Pilot Projects; Recurrence; Streptokinase; Survival Rate; Thrombolytic Therapy; Thrombosis; Ventricular Dysfunction, Left | 1996 |
Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Aspirin; Blood Coagulation Tests; Dalteparin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heparin; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Prospective Studies; Treatment Outcome | 1997 |
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
Topics: Aged; Angina, Unstable; Aspirin; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Recurrence; Risk | 1997 |
Low-molecular-weight heparin (Fragmin) during instability in coronary artery disease (FRISC). FRISC Study Group.
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Aspirin; Dalteparin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Survival Analysis | 1997 |
[Prospective randomized pilot study of ambulatory prevention of thromboembolism. 2 times 500 mg aspirin (ASS) vs. clivarin 1750 (NMH)].
Topics: Adult; Aged; Ambulatory Care; Anticoagulants; Aspirin; Casts, Surgical; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heparin, Low-Molecular-Weight; Humans; Leg Injuries; Male; Middle Aged; Pilot Projects; Prospective Studies; Thromboembolism | 1998 |
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Double-Blind Method; Drug Administration Routes; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Safety; Survival Rate; Treatment Outcome | 1998 |
Low-molecular-weight heparins in coronary stenting (the ENTICES trial). ENoxaparin and TIClopidine after Elective Stenting.
Topics: Aged; Aspirin; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome | 1998 |
Long-term management--the way forward?
Topics: Angina, Unstable; Anticoagulants; Aspirin; Coronary Artery Disease; Dalteparin; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Humans; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2000 |
Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Dalteparin; Double-Blind Method; Female; Fibrinolytic Agents; Humans; Injections, Subcutaneous; Male; Middle Aged; Norway; Recurrence; Stroke; Treatment Outcome | 2000 |
[The drug prevention of postoperative thromboses in patients with critical lower limb ischemia].
Topics: Anticoagulants; Aspirin; Critical Illness; Humans; Ischemia; Leg; Nadroparin; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Thrombosis; Ticlopidine; Time Factors; Vascular Surgical Procedures | 1999 |
Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy.
Topics: Aged; Angina, Unstable; Aspirin; Drug Administration Routes; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Myocardial Ischemia; Prognosis; Recurrence; Severity of Illness Index; Survival Rate | 2000 |
Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin.
Topics: Acute Disease; Angina Pectoris; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Female; Heparin; Humans; Incidence; Injections, Subcutaneous; Male; Middle Aged; Mortality; Myocardial Infarction; Myocardial Ischemia; Pilot Projects; Secondary Prevention; Severity of Illness Index; Single-Blind Method | 2000 |
Low-molecular-weight heparins in acute myocardial infarction: rationale and results of a pilot study.
Topics: Aspirin; Drug Administration Routes; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Partial Thromboplastin Time; Pilot Projects; Plasminogen Activators; Platelet Aggregation Inhibitors; Recombinant Proteins; Tissue Plasminogen Activator | 2000 |
Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina.
Topics: Aged; Angina, Unstable; Anticoagulants; Antithrombins; Aspirin; Biomarkers; Blood Platelets; Dalteparin; Disease-Free Survival; Drug Administration Routes; Drug Therapy, Combination; Enoxaparin; Female; Hirudin Therapy; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Survival Rate; Treatment Outcome; von Willebrand Factor | 2000 |
Local delivery of enoxaparin to decrease restenosis after stenting: results of initial multicenter trial: Polish-American Local Lovenox NIR Assessment study (The POLONIA study).
Topics: Anticoagulants; Aspirin; Drug Administration Routes; Drug Delivery Systems; Enoxaparin; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Poland; Prospective Studies; Stents; Ticlopidine; Treatment Outcome | 2001 |
Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Double-Blind Method; Enoxaparin; Female; Heparin; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Risk Assessment; Syndrome | 2001 |
Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II).
Topics: Anticoagulants; Aspirin; Coronary Angiography; Coronary Circulation; Enoxaparin; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Intracranial Hemorrhages; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Recombinant Proteins; Survival Rate; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2001 |
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.
Topics: Aged; Aged, 80 and over; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Male; Stroke; Tinzaparin; Treatment Outcome; Venous Thrombosis | 2001 |
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial.
Topics: Aged; Analysis of Variance; Anticoagulants; Aspirin; Coronary Disease; Coronary Thrombosis; Double-Blind Method; Drug Administration Routes; Drug Therapy, Combination; Enoxaparin; Female; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Stents; Ticlopidine; Treatment Outcome | 2001 |
Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Enoxaparin; Female; Hemorrhage; Humans; Infant, Newborn; Lupus Erythematosus, Systemic; Nervous System Diseases; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pregnancy, Multiple; Safety; Thrombosis; Warfarin | 2001 |
Enoxaparin sodium improves pregnancy outcome in aspirin-resistant antiphospholipid/antiprotein antibody syndromes.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Resistance; Enoxaparin; Female; Humans; Pregnancy; Pregnancy Outcome | 2002 |
Use of clopidogrel loading, enoxaparin, and double-bolus eptifibatide in the setting of early percutaneous coronary intervention for acute coronary syndromes.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Peptides; Pilot Projects; Platelet Aggregation Inhibitors; Preoperative Care; Ticlopidine; Treatment Outcome | 2002 |
Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Topics: Ambulatory Care; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Cost-Benefit Analysis; Dalteparin; Decision Support Techniques; Drug Costs; Elective Surgical Procedures; Enoxaparin; Fibrinolytic Agents; Hemorrhage; Humans; Markov Chains; Models, Theoretical; Postoperative Complications; Postoperative Period; Recurrence; Thrombosis; Warfarin | 2002 |
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine | 2002 |
Antithrombotic effects of DX-9065a, a direct factor Xa inhibitor: a comparative study in humans versus low molecular weight heparin.
Topics: Adult; Aspirin; Blood Coagulation Tests; Cross-Over Studies; Drug Therapy, Combination; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorheology; Hemostasis; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Naphthalenes; Propionates; Stress, Mechanical | 2002 |
Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide.
Topics: Acute Disease; Aged; Aspirin; Coronary Disease; Electrocardiography; Enoxaparin; Eptifibatide; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Monitoring, Physiologic; Myocardial Ischemia; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Secondary Prevention; Survival Analysis; Treatment Outcome | 2003 |
Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study.
Topics: Abciximab; Administration, Cutaneous; Aged; Antibodies, Monoclonal; Anticoagulants; Aspirin; Blood Flow Velocity; Chemotherapy, Adjuvant; Coronary Angiography; Dalteparin; Drug Therapy, Combination; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Male; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Recurrence; Tissue Plasminogen Activator; Treatment Outcome; Vascular Patency | 2003 |
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial
Topics: Administration, Oral; Aspirin; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Female; Fibrinolytic Agents; Heparin; Humans; Incidence; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Time Factors; Tirofiban; Tyrosine | 2003 |
Nadroparin plus aspirin versus aspirin alone in the treatment of acute ischemic stroke.
Topics: Anticoagulants; Aspirin; Brain Ischemia; Drug Therapy, Combination; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Nadroparin; Stroke | 2003 |
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel
Topics: Aged; Aspirin; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Treatment Outcome | 2004 |
Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.
Topics: Aspirin; Birth Weight; Enoxaparin; Female; Fetal Death; Folic Acid; Heparin, Low-Molecular-Weight; Humans; Odds Ratio; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Thrombophilia | 2004 |
Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction.
Topics: Abciximab; Aged; Aged, 80 and over; Antibodies, Monoclonal; Aspirin; Drug Administration Schedule; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Survival Rate; Tenecteplase; Tissue Plasminogen Activator | 2004 |
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
Topics: Aged; Angina Pectoris; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dalteparin; Female; Heparin; Humans; Pilot Projects; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2004 |
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Atrial Fibrillation; Blood Loss, Surgical; Cohort Studies; Dalteparin; Elective Surgical Procedures; Feasibility Studies; Heart Valve Prosthesis Implantation; Humans; International Normalized Ratio; Intraoperative Complications; Postoperative Complications; Postoperative Hemorrhage; Premedication; Preoperative Care; Prospective Studies; Risk; Thromboembolism; Treatment Outcome; Vitamin K; Warfarin | 2004 |
Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial.
Topics: Aspirin; Coronary Disease; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
[Dysaggregants effect of platelet aggregation in patients with non-ST segment elevation acute coronary syndrome].
Topics: Acute Disease; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Electrocardiography; Female; Humans; Male; Nadroparin; Platelet Aggregation Inhibitors; Syndrome; Ticlopidine | 2004 |
[Safety and efficacy of dalteparin administration for elective percutaneous interventions in patients pre-treated with aspirin and ticlopidine].
Topics: Adolescent; Adult; Aged; Angioplasty, Balloon; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dalteparin; Double-Blind Method; Drug Therapy, Combination; Elective Surgical Procedures; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Preoperative Care; Prospective Studies; Survival Rate; Ticlopidine | 2004 |
Consideration of the total ST-segment deviation on the initial electrocardiogram for predicting final acute posterior myocardial infarct size in patients with maximum ST-segment deviation as depression in leads V1 through V3. A FRISC II substudy.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Coronary Disease; Dalteparin; Electrocardiography; Female; Fibrinolytic Agents; Follow-Up Studies; Forecasting; Heart Ventricles; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Placebos; Platelet Aggregation Inhibitors; Prospective Studies | 2005 |
[Indirect comparison of changes of parameters of hemostasis during short-term use of ticlopidine and clopidogrel in patients with non-ST elevation acute coronary syndrome].
Topics: Anticoagulants; Aspirin; Clopidogrel; Electrocardiography; Enoxaparin; Fibrinolysis; Fibrinolytic Agents; Hemostasis; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Syndrome; Thrombin; Ticlopidine; Time Factors | 2005 |
Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin
Topics: Angina, Unstable; Anticoagulants; Aspirin; Enoxaparin; Eptifibatide; Female; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome | 2006 |
Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin.
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Humans; Male; Prospective Studies; Venous Thrombosis | 2006 |
A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clopidogrel; Drug Therapy, Combination; Enoxaparin; Feasibility Studies; Female; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Tenecteplase; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator | 2006 |
A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages.
Topics: Abortion, Habitual; Abortion, Induced; Adult; Anticoagulants; Aspirin; Birth Rate; Birth Weight; Enoxaparin; Female; Humans; Incidence; Infant, Newborn; Infant, Newborn, Diseases; Live Birth; Middle Aged; Obstetric Labor, Premature; Placenta; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications; Regional Blood Flow; Ultrasonography | 2006 |
VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Spinal; Arthroplasty, Replacement, Knee; Aspirin; Combined Modality Therapy; Enoxaparin; Female; Fibrinolytic Agents; Humans; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Postoperative Care; Thromboembolism; Ultrasonography; Venous Thrombosis | 2006 |
Efficacy and safety of clopidogrel 600 mg administered pre-hospitally to improve primary percutaneous coronary intervention in patients with acute myocardial infarction (CIPAMI): study rationale and design.
Topics: Adult; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug Administration Schedule; Enoxaparin; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Research Design; Ticlopidine; Treatment Outcome | 2007 |
Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Dalteparin; Drug Therapy, Combination; Female; Femoral Artery; Fibrinolytic Agents; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Intermittent Claudication; Ischemia; Lower Extremity; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Popliteal Artery; Proportional Hazards Models; Prospective Studies; Research Design; Secondary Prevention; Severity of Illness Index; Time Factors; Treatment Outcome; Ultrasonography; Vascular Patency | 2006 |
Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction.
Topics: Aged; Aspirin; Blood Coagulation; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Platelet Count; Thrombocytopenia; Thrombolytic Therapy; Time Factors; Tomography Scanners, X-Ray Computed; Treatment Outcome | 2006 |
Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Arterial Occlusive Diseases; Asian People; Aspirin; Brain Ischemia; Female; Hemorrhage; Humans; Injections, Subcutaneous; Male; Middle Aged; Nadroparin; Stroke; Treatment Outcome | 2007 |
Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthroplasty; Aspirin; Azetidines; Benzylamines; Bleeding Time; Blood Loss, Surgical; Blood Transfusion; Double-Blind Method; Enoxaparin; Europe; Female; Humans; Lower Extremity; Male; Middle Aged; Platelet Aggregation Inhibitors; South Africa; Thrombosis | 2006 |
Sex differences in quality of life in stroke survivors: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST).
Topics: Activities of Daily Living; Age Factors; Aged; Aspirin; Brain Ischemia; Double-Blind Method; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Male; Mental Disorders; Mental Health; Middle Aged; Prognosis; Prospective Studies; Quality of Life; Recovery of Function; Sex Characteristics; Sex Factors; Stroke; Surveys and Questionnaires; Survival Rate; Tinzaparin; Treatment Outcome | 2007 |
Safety and effectiveness of tinzaparin sodium in the management of recurrent pregnancy loss.
Topics: Abortion, Habitual; Adult; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Outcome; Thrombophilia; Tinzaparin | 2007 |
Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRAC
Topics: Aged; Aspirin; Diabetes Complications; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies | 2007 |
Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Aspirin; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Humans; Live Birth; Prednisone; Pregnancy; Pregnancy Outcome; Progesterone; Progestins; Prospective Studies; Single-Blind Method | 2008 |
Dalteparin in the management of recent onset central retinal vein occlusion: a comparison with acetylsalicylic acid.
Topics: Administration, Oral; Aspirin; Dalteparin; Female; Fibrinolytic Agents; Humans; Injections, Subcutaneous; Male; Middle Aged; Retinal Vein Occlusion; Treatment Outcome; Visual Acuity | 2008 |
Dalteparin versus aspirin in recent-onset branch retinal vein occlusion: a randomized clinical trial.
Topics: Aspirin; Dalteparin; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Retinal Vein Occlusion; Time Factors | 2008 |
Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aspirin; Chromatography, High Pressure Liquid; Drug Interactions; Enoxaparin; Female; Fibrinolytic Agents; Glycosaminoglycans; Glycosides; Humans; Liver Function Tests; Male; Middle Aged; Young Adult | 2008 |
Long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion.
Topics: Aspirin; Dalteparin; Female; Fibrinolytic Agents; Humans; Iris; Male; Middle Aged; Neovascularization, Pathologic; Retinal Vein Occlusion | 2008 |
Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosis. Results of an in-vitro study.
Topics: Anticoagulants; Aspirin; Cardiac Catheterization; Enoxaparin; Eptifibatide; Erythrocytes; Fibrin; Fibrinolytic Agents; Heparin; Hirudins; Humans; In Vitro Techniques; Male; Microscopy, Electron, Scanning; Peptide Fragments; Peptides; Perfusion; Platelet Aggregation Inhibitors; Recombinant Proteins; Thrombosis | 2008 |
Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation.
Topics: Aged; Anticoagulants; Aspirin; Dipyridamole; Heart Failure; Heart-Assist Devices; Heparin; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Nadroparin; Outcome Assessment, Health Care; Postoperative Period; Prostheses and Implants; Thrombosis | 2008 |
The relationship between baseline blood pressure and computed tomography findings in acute stroke: data from the tinzaparin in acute ischaemic stroke trial (TAIST).
Topics: Acute Disease; Aspirin; Blood Pressure; Brain; Brain Ischemia; Causality; Cerebral Hemorrhage; Comorbidity; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Hypertension; Incidence; Leukoaraiosis; Stroke; Tinzaparin; Tomography, X-Ray Computed | 2009 |
Low molecular weight heparin significantly reduces embolisation after carotid endarterectomy--a randomised controlled trial.
Topics: Adenosine Diphosphate; Aged; Anticoagulants; Arachidonic Acid; Aspirin; Carotid Artery Diseases; Dalteparin; Double-Blind Method; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Intracranial Embolism; Male; Middle Aged; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2009 |
Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study.
Topics: Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fibrinolytic Agents; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Retinal Vein Occlusion; Treatment Outcome | 2010 |
Use of heparin in women with early and late miscarriages with and without thrombophilia.
Topics: Abortion, Habitual; Adult; Age Factors; Aspirin; Biomarkers; Case-Control Studies; Dalteparin; Drug Therapy, Combination; Female; Heparin, Low-Molecular-Weight; Humans; Inflammation; Live Birth; Pregnancy; Pregnancy Outcome; Thrombophilia; Young Adult | 2009 |
5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary
Topics: Abciximab; Acute Coronary Syndrome; Adolescent; Adult; Aged; Aged, 80 and over; Angina, Unstable; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Angiography; Electrocardiography; Enoxaparin; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Revascularization; Netherlands; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Survival Rate; Ticlopidine; Time Factors; Treatment Outcome; Young Adult | 2010 |
SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Outcome; Scotland | 2010 |
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Contusions; Drug Therapy, Combination; Female; Humans; Live Birth; Nadroparin; Platelet Aggregation Inhibitors; Pregnancy; Treatment Failure; Young Adult | 2010 |
The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study.
Topics: Aged; Aspirin; Cardiac Catheterization; Cause of Death; Clopidogrel; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Fibrinolytic Agents; Follow-Up Studies; Humans; Myocardial Infarction; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Prospective Studies; Survival Rate; Thrombolytic Therapy; Ticlopidine; Time Factors; Treatment Outcome | 2010 |
Randomised controlled trial evaluating the role of tirofiban in high-risk non-ST elevation acute coronary syndromes: an East Indian perspective.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Emergency Service, Hospital; Enoxaparin; Female; Follow-Up Studies; Humans; India; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Reference Values; Severity of Illness Index; Survival Rate; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine | 2010 |
Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial.
Topics: Aged; Anticoagulants; Aspirin; Cerebral Hemorrhage; Cerebral Infarction; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Tinzaparin; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Drug Therapy, Combination; Early Termination of Clinical Trials; Enoxaparin; Europe; Female; Fibrinolytic Agents; Gestational Age; Humans; Live Birth; Patient Selection; Pregnancy; Thrombophilia; Treatment Outcome; Young Adult | 2011 |
Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Enoxaparin; Female; Hemorrhage; Heparin; Humans; Infant, Newborn; Osteoporotic Fractures; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Thrombocytopenia; Treatment Outcome | 2011 |
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
Topics: Aged; Anticoagulants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Cardiovascular Diseases; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Humans; Italy; Male; Middle Aged; Multiple Myeloma; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Thalidomide; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2011 |
Quality of life after ischemic stroke varies in western countries: data from the tinzaparin in Acute Ischaemic Stroke Trial (TAIST).
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Chi-Square Distribution; Emotions; Europe; Female; Fibrinolytic Agents; Healthcare Disparities; Heparin, Low-Molecular-Weight; Humans; Linear Models; Male; Mental Health; Middle Aged; North America; Prospective Studies; Quality of Life; Recovery of Function; Residence Characteristics; Stroke; Surveys and Questionnaires; Time Factors; Tinzaparin; Treatment Outcome | 2012 |
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.
Topics: Adult; Anticoagulants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Enoxaparin; Female; Humans; Incidence; Israel; Italy; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Platelet Aggregation Inhibitors; Pulmonary Embolism; Risk Factors; Thalidomide; Venous Thromboembolism; Venous Thrombosis | 2012 |
Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Embryo Loss; Female; Heparin, Low-Molecular-Weight; Humans; Iraq; Live Birth; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Outcome; Treatment Outcome; Young Adult | 2012 |
Comparison of enoxaparin and unfractionated heparin in endovascular interventions for the treatment of peripheral arterial occlusive disease: a randomized controlled trial.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Drug Therapy, Combination; Endothelium, Vascular; Enoxaparin; Factor Xa Inhibitors; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Peripheral Arterial Disease; Treatment Outcome | 2011 |
On-treatment function testing of platelets and long-term outcome of patients with peripheral arterial disease undergoing transluminal angioplasty.
Topics: Aged; Aged, 80 and over; Angioplasty; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Dalteparin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ischemia; Leg; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation; Platelet Function Tests; Risk Factors; Secondary Prevention; Statistics as Topic; Treatment Outcome | 2011 |
Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial.
Topics: Anticoagulants; Aspirin; Cohort Studies; Disease Progression; Enoxaparin; Female; Follow-Up Studies; Gravidity; Humans; Pilot Projects; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Treatment Outcome | 2011 |
Spot drug-eluting stenting for long coronary stenoses: long-term results of a randomized clinical study.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Enoxaparin; Female; Humans; Male; Proportional Hazards Models; Risk Assessment; Severity of Illness Index; Ticlopidine; Time Factors; Ultrasonography, Interventional | 2011 |
Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Female; Hong Kong; Humans; Intracranial Arterial Diseases; Male; Middle Aged; Nadroparin; Platelet Aggregation Inhibitors; Prospective Studies; Singapore; Stroke; Treatment Outcome; Young Adult | 2012 |
Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction.
Topics: Acute Coronary Syndrome; Aged; Anti-Ulcer Agents; Aspirin; Chi-Square Distribution; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Esomeprazole; Famotidine; Female; Fibrinolytic Agents; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intestinal Perforation; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Ticlopidine; Treatment Outcome | 2012 |
Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Drug Interactions; Enoxaparin; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Platelet Aggregation Inhibitors; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2012 |
Transient heparin-induced platelet activation linked to generation of platelet 12-lipoxygenase. Findings from a randomised controlled trial.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adenosine Diphosphate; Aged; Arachidonate 12-Lipoxygenase; Aspirin; Blood Platelets; Dalteparin; Endarterectomy, Carotid; Female; Gene Expression Regulation, Enzymologic; Heparin; Humans; Lipase; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Thromboxane B2 | 2013 |
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial.
Topics: Adult; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Dalteparin; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Venous Thromboembolism | 2013 |
Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Aspirin; Birth Weight; Embryo Implantation; Enoxaparin; Female; Fibrinolytic Agents; Humans; Infant, Newborn; Libya; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Prostaglandins I; Thrombophilia; Thromboxane A2; Trophoblasts; Vasodilation; Young Adult | 2014 |
Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Ischemia; Enoxaparin; Female; Humans; Male; Middle Aged; Nervous System Diseases; Stroke; Treatment Outcome; Venous Thromboembolism | 2014 |
Effect of Preoperative Aspirin Replacement With Enoxaparin in Patients Undergoing Primary Isolated On-Pump Coronary Artery Bypass Grafting.
Topics: Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, Drug; Elective Surgical Procedures; Enoxaparin; Female; Follow-Up Studies; Humans; Incidence; Italy; Male; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Preoperative Care; Propensity Score; Radiography; Retrospective Studies | 2016 |
Eptifibatide infusion versus placebo in high risk patients with non-ST segment elevation acute coronary syndromes managed with urgent coronary artery bypass graft surgery. A prospective multicenter randomized placebo-controlled clinical trial.
Topics: Acute Coronary Syndrome; Aspirin; Coronary Artery Bypass; Enoxaparin; Eptifibatide; Female; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Prospective Studies; Treatment Outcome | 2016 |
Randomized controlled study of pre-conception thromboprophylaxis among patients with recurrent spontaneous abortion related to antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Egypt; Enoxaparin; Female; Fibrinolytic Agents; Humans; Intention to Treat Analysis; Live Birth; Preconception Care; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Rate | 2016 |
Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial.
Topics: Abruptio Placentae; Adult; Aspirin; Drug Therapy, Combination; Enoxaparin; Female; Humans; Pre-Eclampsia; Pregnancy | 2016 |
Deep Venous Thrombosis Prophylaxis After Unicompartmental Knee Arthroplasty: A Prospective Study on the Safety of Aspirin.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Humans; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Postoperative Period; Prospective Studies; Pulmonary Embolism; Risk; Ultrasonography, Doppler; Venous Thromboembolism; Venous Thrombosis | 2017 |
The Prevalence of Thrombophilia in Women With Recurrent Fetal Loss and Outcome of Anticoagulation Therapy for the Prevention of Miscarriages.
Topics: Abortion, Habitual; Adolescent; Adult; Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Prevalence; Retrospective Studies; Thrombophilia | 2018 |
Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Enoxaparin; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Pilot Projects; Retrospective Studies; Stroke; Treatment Outcome; Young Adult | 2018 |
Acetylsalicylic acid decreases clotting in combination with enoxaparin during haemodialysis in vitro.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Blood Coagulation; Drug Therapy, Combination; Enoxaparin; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Renal Dialysis; Young Adult | 2019 |
Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial.
Topics: Adult; Aged; Anticoagulants; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Fractures, Bone; Hemorrhage; Humans; Male; Middle Aged; Treatment Outcome; Venous Thromboembolism; Young Adult | 2020 |
Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Australia; Chemoprevention; Enoxaparin; Female; Humans; Male; Osteoarthritis; Postoperative Complications; Pulmonary Embolism; Venous Thromboembolism | 2022 |
Review of Article: CRISTAL Study Group. Effect of aspirin vs. enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: The CRISTAL randomized trial. JAMA. 2022;328(8):719-727.
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Humans; Venous Thromboembolism | 2022 |
Is Enoxaparin Associated With a Higher Risk of Persistent Wound Drainage Than Aspirin? A Secondary Analysis of Data From the CRISTAL Randomized Trial.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Australia; Drainage; Enoxaparin; Humans; Male; Middle Aged; Postoperative Complications; Venous Thromboembolism | 2023 |
Effect of Rivaroxaban vs Enoxaparin on Major Cardiac Adverse Events and Bleeding Risk in the Acute Phase of Acute Coronary Syndrome: The H-REPLACE Randomized Equivalence and Noninferiority Trial.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Enoxaparin; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Prospective Studies; Rivaroxaban | 2023 |
Effect of Aspirin vs Enoxaparin on 90-Day Mortality in Patients Undergoing Hip or Knee Arthroplasty: A Secondary Analysis of the CRISTAL Cluster Randomized Trial.
Topics: Adolescent; Adult; Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Female; Humans; Male; Venous Thromboembolism | 2023 |
193 other study(ies) available for aspirin and dalteparin
| Article | Year |
|---|---|
Effect of the low molecular weight heparin/non steroidal anti-inflammatory drugs association on an experimental thrombosis induced by laser.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combination; Indomethacin; Injections, Subcutaneous; Ketoprofen; Lasers; Male; Nadroparin; Piroxicam; Platelet Aggregation; Rats; Rats, Wistar; Thrombolytic Therapy; Thrombosis | 1995 |
Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs.
Topics: Animals; Aspirin; Coronary Thrombosis; Dogs; Heparin; Myocardial Reperfusion; Nadroparin; Thrombolytic Therapy; Tissue Plasminogen Activator | 1995 |
High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: immunological changes associated with a successful outcome.
Topics: Adult; Antibodies, Anti-Idiotypic; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Chromatography, Affinity; Combined Modality Therapy; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulins, Intravenous; Nadroparin; Platelet Count; Pregnancy; Pregnancy Complications; Treatment Outcome | 1994 |
Increased blood loss after preoperative NSAID. Retrospective study of 186 hip arthroplasties.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Loss, Surgical; Enoxaparin; Female; Hip Prosthesis; Humans; Male; Middle Aged; Premedication; Retrospective Studies | 1993 |
Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects.
Topics: Aspirin; Heparin; Heparin, Low-Molecular-Weight; Humans; In Vitro Techniques; Partial Thromboplastin Time; Platelet Activation; Reference Values; Thrombin | 1993 |
Low-molecular-weight heparin for the treatment of acute ischemic stroke.
Topics: Acute Disease; Aspirin; Brain Ischemia; Fibrinolytic Agents; Humans; Nadroparin; Platelet Aggregation Inhibitors | 1996 |
Increasing the stability of unstable angina.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Dalteparin; Drug Therapy, Combination; Humans; Treatment Outcome; Vasodilator Agents | 1997 |
Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Topics: Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Collagen; Coronary Thrombosis; Dogs; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Enoxaparin; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Hemostasis; Heparin; Hirudin Therapy; Hirudins; Male; Partial Thromboplastin Time; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Prothrombin; Prothrombin Time; Recombinant Proteins; Recurrence; Safety; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator | 1997 |
XIX congress of the European Society of Cardiology August 24-28, 1997, Stockholm, Sweden.
Topics: Amiodarone; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Anticoagulants; Arteriosclerosis; Aspirin; Cardiology; Coronary Disease; Enoxaparin; Eptifibatide; Europe; Humans; Peptides; Platelet Aggregation Inhibitors; Societies, Medical; Thrombolytic Therapy | 1997 |
[Pulmonary embolism as one cause of death after spinal injury--the role of clexane].
Topics: Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Male; Middle Aged; Poland; Pulmonary Embolism; Retrospective Studies; Spinal Injuries; Survival Rate | 1998 |
Aspirin and fraxiparine in the prevention of laser induced thrombosis in the presence of iodinated contrast media.
Topics: Animals; Aspirin; Contrast Media; Diatrizoate; Fibrinolytic Agents; Hemoglobins; Iodine Radioisotopes; Iohexol; Iopamidol; Ioxaglic Acid; Lasers; Male; Nadroparin; Platelet Aggregation; Rats; Rats, Wistar; Thromboembolism | 1998 |
The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidine.
Topics: Adenosine Diphosphate; Adult; Analysis of Variance; Anticoagulants; Aspirin; Chemoprevention; Citric Acid; Collagen; Drug Interactions; Enoxaparin; Factor XIIa; Flow Cytometry; Humans; Male; P-Selectin; Plant Proteins; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Trypsin Inhibitors; Zea mays | 1999 |
Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology.
Topics: Abciximab; Alanine; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Aspirin; Benzamidines; Biphenyl Compounds; Cardiology; Cardiovascular Agents; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Disease; Dalteparin; Defibrillators, Implantable; Double-Blind Method; Enalapril; Endothelial Growth Factors; Fatty Acids, Omega-3; Guanidines; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Laser Therapy; Lymphokines; Metoprolol; Multicenter Studies as Topic; Myocardial Revascularization; Platelet Aggregation Inhibitors; Pyrrolidines; Randomized Controlled Trials as Topic; Simvastatin; Sodium-Hydrogen Exchangers; Stents; Sulfones; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitamin E | 1999 |
Enoxaparin and dalteparin in unstable angina: new indication. Enoxaparin: a reference treatment. Dalteparin: no better than unfractionated heparin.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Dalteparin; Enoxaparin; Humans; Myocardial Infarction; Treatment Outcome | 1999 |
Low molecular weight heparins in acute coronary syndrome.
Topics: Acute Disease; Angina, Unstable; Anticoagulants; Aspirin; Dalteparin; Double-Blind Method; Enoxaparin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Placebos; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Time Factors | 2000 |
The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Factor V; Female; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Thrombosis; Treatment Outcome | 2000 |
Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Topics: 3' Untranslated Regions; Abortion, Habitual; Activated Protein C Resistance; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Birth Weight; Cesarean Section; Drug Therapy, Combination; Enoxaparin; Factor V; Female; Humans; Infant, Newborn; Methylenetetrahydrofolate Reductase (NADPH2); Obstetric Labor, Premature; Oxidoreductases Acting on CH-NH Group Donors; Placenta; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Prothrombin; Thrombophilia; Thrombosis; Venous Thrombosis | 2000 |
Heparin vs aspirin in acute ischaemic stroke.
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Dalteparin; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Stroke | 2000 |
Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
Topics: Angina, Unstable; Angioplasty; Anticoagulants; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Artery Bypass; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome | 2000 |
Images in clinical radiology. Updated MR work-up of hyperacute stroke.
Topics: Aspirin; Echo-Planar Imaging; Fibrinolytic Agents; Humans; Image Enhancement; Infarction, Anterior Cerebral Artery; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Middle Aged; Nadroparin; Platelet Aggregation Inhibitors; Stroke | 1999 |
New drugs, or new trials of current drugs, for the treatment of acute ischaemic stroke?
Topics: Aspirin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Stroke; Tinzaparin | 2001 |
Enoxaparin treatment in women with mechanical heart valves during pregnancy.
Topics: Adult; Antibodies; Anticoagulants; Aspirin; Enoxaparin; Factor Xa; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prospective Studies; Thrombosis | 2001 |
[High or middle dose tinzaparin versus aspirin for the treatment of cerebral ischemic accident].
Topics: Aspirin; Brain Ischemia; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Tinzaparin | 2001 |
Hemorrhagic complications of enoxaparin and aspirin in patients with kidney transplants.
Topics: Adult; Aged; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Hemoglobins; Humans; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Postoperative Hemorrhage; Retrospective Studies | 2002 |
Early anticoagulation in acute ischaemic stroke.
Topics: Aspirin; Clinical Trials as Topic; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Stroke; Tinzaparin | 2002 |
Antiplatelet aggregating versus anticoagulant agents in preventing early recurrent stroke among patients with atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Dalteparin; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2001 |
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes.
Topics: Age Factors; Aged; Angina, Unstable; Area Under Curve; Aspirin; Biomarkers; Body Weight; Coronary Artery Disease; Creatinine; Drug Therapy, Combination; Enoxaparin; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Humans; Kidney; Male; Middle Aged; Myocardial Infarction; Sex Factors; Syndrome | 2002 |
Low molecular weight heparin: a bridge over troubled water.
Topics: Anticoagulants; Aspirin; Coronary Artery Disease; Dalteparin; Heparin, Low-Molecular-Weight; Humans; Randomized Controlled Trials as Topic; Warfarin | 2002 |
Preventing adverse obstetric outcomes in women with genetic thrombophilia.
Topics: Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Heparin; Humans; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Thrombophilia | 2002 |
Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy.
Topics: Aged; Anticoagulants; Aspirin; Carcinoma, Basal Cell; Clopidogrel; Drug Administration Schedule; Female; Heparin, Low-Molecular-Weight; Humans; Mohs Surgery; Nose Neoplasms; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Skin Neoplasms; Ticlopidine; Venous Thrombosis | 2002 |
Thrombophilic causes of retinal vascular thrombosis: etiology and treatment outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Clinical Laboratory Techniques; Clopidogrel; Dalteparin; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retinal Diseases; Retinal Vessels; Thrombophilia; Thrombosis; Ticlopidine; Treatment Outcome | 2002 |
Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trials.
Topics: Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Aspirin; Creatinine; Drug Monitoring; Enoxaparin; Factor Xa; Female; Fibrinolytic Agents; Hemorrhage; Humans; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Patient Selection; Randomized Controlled Trials as Topic; Renal Insufficiency; Risk Assessment; Treatment Outcome | 2003 |
Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Dalteparin; Endothelium, Vascular; Female; Fetal Growth Retardation; Fetal Membranes, Premature Rupture; Hemostasis; Humans; Longitudinal Studies; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Reference Values; Thrombosis | 2003 |
Atrial fibrillation, stroke, and acute antithrombotic therapy.
Topics: Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Tinzaparin; Treatment Outcome; Venous Thrombosis | 2003 |
The effect of anticoagulation on the restoration of range of motion after total knee arthroplasty: enoxaparin versus aspirin.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Hemarthrosis; Humans; Knee Joint; Male; Postoperative Hemorrhage; Range of Motion, Articular; Recovery of Function; Treatment Outcome; Venous Thrombosis | 2003 |
Glycoprotein IIb/IIIa receptor antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-[[2-([4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl]amino)acetyl]amino]propanoic acid dihydrochloride (CRL42796), in combination with aspirin and/or enoxaparin, preven
Topics: Animals; Aspirin; Blood Coagulation; Coronary Thrombosis; Dipeptides; Disease Models, Animal; Dogs; Drug Therapy, Combination; Enoxaparin; Female; Hemodynamics; Male; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Reperfusion; Sulfonamides; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator | 2003 |
[Successful pregnancy outcome in the woman with thrombophilia and multiple miscarriages].
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Cesarean Section; Factor V; Female; Heterozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Nadroparin; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Thrombophilia; Time Factors | 2003 |
Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.
Topics: Adult; Aspirin; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Therapy, Combination; Eczema; Enoxaparin; Female; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications | 2003 |
[Branch retinal arterial occlusions--clinical case].
Topics: Aged; Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Fundus Oculi; Humans; Male; Nadroparin; Retinal Artery Occlusion; Treatment Outcome | 2003 |
Efficiency in clinical research: assessment in vitro of potential anti-thrombotic drug interactions.
Topics: Adult; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Flow Cytometry; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation Inhibitors | 2004 |
Hemorrhagic transformation of ischemic stroke associated with enoxaparin and aspirin concomitant therapy.
Topics: Acute Disease; Anticoagulants; Aspirin; Cerebral Hemorrhage; Drug Therapy, Combination; Enoxaparin; Humans; Male; Middle Aged; Stroke | 2004 |
Life-threatening bleeding, pregnancy and lupus anticoagulant: success after steroid and anticoagulant therapy.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Glucocorticoids; Humans; Lupus Coagulation Inhibitor; Phospholipids; Prednisone; Pregnancy; Uterine Hemorrhage | 2004 |
Anticoagulation interruptus: not without risk.
Topics: Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Blood Loss, Surgical; Carotid Arteries; Dalteparin; Drug Administration Schedule; Elective Surgical Procedures; Filtration; Heart Valve Prosthesis Implantation; Humans; International Normalized Ratio; Intraoperative Care; Postoperative Care; Postoperative Complications; Postoperative Hemorrhage; Premedication; Stents; Thromboembolism; Thrombosis; Vitamin K; Warfarin | 2004 |
[Two approaches to correction of disturbed hemostasis in patients with mechanical artificial heart valves at the long-term follow-up].
Topics: Aspirin; Blood Coagulation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Nadroparin; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Treatment Outcome | 2004 |
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Degranulation; Dalteparin; Drug Synergism; Heparin; Hirudins; Humans; In Vitro Techniques; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12 | 2005 |
Prophylaxis with enoxaparin can produce a giant abdominal wall haematoma when associated with low doses of aspirin among elderly patients suffering cough attacks.
Topics: Abdominal Wall; Aged; Aged, 80 and over; Aspirin; Cough; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enoxaparin; Female; Hematoma; Humans; Male; Myocardial Ischemia; Rectus Abdominis; Tomography, X-Ray Computed | 2005 |
A protocol for the use of enoxaparin during pregnancy: results from 85 pregnancies including 13 multiple gestation pregnancies.
Topics: Adult; Aspirin; Clinical Protocols; Dose-Response Relationship, Drug; Drug Monitoring; Enoxaparin; Female; Fetus; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Pregnancy; Pregnancy Outcome; Pregnancy, Multiple; Risk Factors | 2005 |
An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease.
Topics: Abciximab; Adult; Aged; Angina, Unstable; Antibodies, Monoclonal; Anticoagulants; Aspirin; C-Reactive Protein; Case-Control Studies; Cohort Studies; Coronary Disease; Dalteparin; Female; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Inflammation Mediators; Interleukin-6; Kinetics; Male; Middle Aged; Multicenter Studies as Topic; Myocardium; Prospective Studies; Randomized Controlled Trials as Topic; Troponin T | 2005 |
Exploring the role of enoxaparin in the management of high-risk patients with non-ST-elevation acute coronary syndromes: the SYNERGY trial.
Topics: Aged; Anticoagulants; Aspirin; Cardiac Catheterization; Enoxaparin; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Syndrome | 2005 |
Massive rectus sheath hematoma.
Topics: Aged; Anticoagulants; Aspirin; Cardiovascular Diseases; Enoxaparin; Epigastric Arteries; Female; Hematoma; Humans; Rectus Abdominis; Tomography, X-Ray Computed | 2006 |
Arterial antithrombotic effects of aspirin, heparin, enoxaparin and clopidogrel alone, or in combination, in the rat.
Topics: Animals; Anticoagulants; Aspirin; Bleeding Time; Carotid Arteries; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enoxaparin; Heparin; Male; Models, Animal; Rats; Rats, Sprague-Dawley; Thrombosis; Ticlopidine | 2006 |
Are low doses of enoxaparin with aspirin sufficient to guarantee good gestational outcome in women with heterozygote factor V Leiden mutation?
Topics: Abortion, Spontaneous; Adult; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Factor V; Female; Heterozygote; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Outcome | 2007 |
Acute myocardial infarction in a patient with severe unrecognized mitral stenosis.
Topics: Analgesics; Anti-Arrhythmia Agents; Anticholesteremic Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Diuretics; Echocardiography, Transesophageal; Electrocardiography; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Hydrochlorothiazide; Metoprolol; Middle Aged; Mitral Valve Stenosis; Myocardial Infarction; Nadroparin; Simvastatin; Time Factors; Treatment Outcome | 2006 |
Successful lysis of coronary thrombi by long term warfarin treatment after a failed course of tirofiban infusion.
Topics: Angina Pectoris; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Enoxaparin; Female; Humans; Infusion Pumps; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Tirofiban; Treatment Failure; Treatment Outcome; Tyrosine; Warfarin | 2006 |
Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Black or African American; Blood Coagulation; Case-Control Studies; Clopidogrel; Drug Interactions; Enoxaparin; Female; Gastrointestinal Hemorrhage; Hispanic or Latino; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ticlopidine; Warfarin; White People | 2006 |
The natural course of women with recurrent fetal loss.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Outcome; Thrombophilia | 2006 |
Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment.
Topics: Abciximab; Adult; Aged; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Anticoagulants; Aspirin; Cardiac Catheterization; Clopidogrel; Enoxaparin; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Thrombosis; Ticlopidine | 2006 |
Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Enoxaparin; Humans; Lenalidomide; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Recurrence; Risk; Thalidomide; Thromboembolism; Time Factors | 2006 |
[When ASS, when anticoagulants?].
Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Aspirin; Clopidogrel; Female; Heart Diseases; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Sex Factors; Stroke; Ticlopidine; Time Factors | 2006 |
Clinical trials update from the annual scientific session of the American College of Cardiology 2006.
Topics: Aspirin; Cardiac Catheterization; Cardiology; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Enoxaparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Societies, Medical; Stents; Thrombolytic Therapy; Ticlopidine; United States | 2006 |
Atraumatic compartment syndrome of the dorsal compartment of the upper arm.
Topics: Acute Disease; Aged; Arm; Aspirin; Compartment Syndromes; Diagnosis, Differential; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Attack, Transient | 2006 |
The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis.
Topics: Animals; Aspartate Aminotransferases; Aspirin; Bilirubin; Disease Progression; Enoxaparin; Fibrinolytic Agents; Fibrosis; Hepatectomy; Liver; Liver Cirrhosis, Experimental; Liver Regeneration; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Thioacetamide | 2007 |
Thromboprophylaxis after hip fracture: evaluation of 3 pharmacologic agents.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Dextrans; Enoxaparin; Female; Fibrinolytic Agents; Follow-Up Studies; Hip Fractures; Humans; Incidence; Male; Pulmonary Embolism; Retrospective Studies; Survival Rate; Treatment Outcome; Venous Thrombosis | 2007 |
Spontaneous dissection of the celiac artery: a case report.
Topics: Abdominal Pain; Analgesics, Opioid; Anticoagulants; Aortic Dissection; Aspirin; Celiac Artery; Diagnosis, Differential; Drug Therapy, Combination; Enoxaparin; Humans; Male; Meperidine; Middle Aged; Platelet Aggregation Inhibitors; Splenic Artery; Splenic Infarction; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2007 |
Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia.
Topics: Abruptio Placentae; Adult; Anticoagulants; Aspirin; Dalteparin; Drug Therapy, Combination; Female; Fetal Death; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Hematologic; Retrospective Studies; Thrombophilia; Treatment Outcome | 2007 |
Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Aspirin; Atherectomy, Coronary; Clopidogrel; Coronary Angiography; Drug Therapy, Combination; Enoxaparin; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Ticlopidine | 2007 |
Enoxaparin and ST elevation myocardial infarction.
Topics: Aspirin; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction | 2007 |
Prolonged transient hand ischaemia secondary to a penicillin skin test.
Topics: Aspirin; Calcium Channel Blockers; Cyanosis; Drug Hypersensitivity; Drug Therapy, Combination; Fibrinolytic Agents; Fingers; Follow-Up Studies; Hand; Humans; Intradermal Tests; Ischemia; Male; Middle Aged; Nadroparin; Nifedipine; Penicillins; Pentoxifylline; Vasodilator Agents | 2007 |
Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clopidogrel; Combined Modality Therapy; Dipyridamole; Early Ambulation; Enoxaparin; Female; Fibrinolytic Agents; Hematologic Agents; Humans; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Platelet Aggregation Inhibitors; Pulmonary Embolism; Retrospective Studies; Risk Assessment; Thromboembolism; Ticlopidine; Venous Thrombosis; Warfarin | 2007 |
Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Enoxaparin; Female; Gastrointestinal Hemorrhage; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Statistics, Nonparametric; Ticlopidine | 2008 |
Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: a prospective cohort of 2736 women.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cohort Studies; Enoxaparin; Female; Humans; Placenta; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prospective Studies; Risk; Risk Factors; Venous Thromboembolism | 2008 |
Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome.
Topics: Alprostadil; Analysis of Variance; Animals; Antiphospholipid Syndrome; Aspirin; Behavior, Animal; beta 2-Glycoprotein I; Central Nervous System; Disease Models, Animal; Enoxaparin; Enzyme-Linked Immunosorbent Assay; Exploratory Behavior; Female; Fibrinolytic Agents; Mice; Mice, Inbred BALB C; Phospholipids; Thrombosis; Tumor Necrosis Factor-alpha | 2008 |
Withholding warfarin therapy for atrial fibrillation patients in the perioperative period.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Enoxaparin; Humans; Perioperative Care; Stroke; Time Factors; Warfarin | 2008 |
[Stents, antiplatelet therapy, and surgery].
Topics: Adult; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cesarean Section; Enoxaparin; Female; Fetal Distress; Humans; Intraoperative Complications; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Stents; Thrombophilia; Thrombosis; Uterine Hemorrhage | 2008 |
Cerebral subarachnoid blood migration consecutive to a lumbar haematoma after spinal anaesthesia.
Topics: Aged; Anesthesia, Spinal; Anesthetics, Intravenous; Anesthetics, Local; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Brain; Bupivacaine; Cerebrovascular Circulation; Enoxaparin; Female; Fibrinolytic Agents; Hematoma; Humans; Low Back Pain; Lumbar Vertebrae; Magnetic Resonance Imaging; Postoperative Nausea and Vomiting; Stupor; Subarachnoid Hemorrhage; Subarachnoid Space; Sufentanil; Tomography, X-Ray Computed | 2008 |
VTE prevention in major orthopedic surgery.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Enoxaparin; Fondaparinux; Humans; Orthopedics; Platelet Aggregation Inhibitors; Polysaccharides; Risk Factors; Venous Thromboembolism | 2008 |
Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis?
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Enoxaparin; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Dysfunction, Right | 2008 |
Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Combined Modality Therapy; Comorbidity; Cyclooxygenase Inhibitors; Disease-Free Survival; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Heart Failure; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Thrombolytic Therapy; Treatment Outcome | 2009 |
Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoantibodies; beta 2-Glycoprotein I; Biomarkers; Cohort Studies; Enoxaparin; Female; Humans; Lupus Coagulation Inhibitor; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications | 2008 |
[Changes in coagulation hemostasis in patients after coronary bypass surgery].
Topics: Anticoagulants; Aspirin; Blood Coagulation Disorders; Coronary Artery Bypass; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Homeostasis; Humans; Male; Middle Aged; Myocardial Ischemia; Nadroparin; Protein C; Thrombin | 2008 |
[Digital ischemia in a gardener: is rose cutting a vascular risk factor?].
Topics: Alprostadil; Aneurysm; Anticoagulants; Aspirin; Diagnosis, Differential; Female; Finger Injuries; Fingers; Gardening; Hobbies; Humans; Ischemia; Magnetic Resonance Angiography; Middle Aged; Nadroparin; Photoplethysmography; Platelet Aggregation Inhibitors; Pulse; Radial Artery; Recurrence; Risk Factors; Treatment Outcome; Ultrasonography, Doppler, Color; Vasodilator Agents | 2008 |
Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine.
Topics: Administration, Oral; Animals; Aspirin; Bioprosthesis; Clopidogrel; Dalteparin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart Valve Prosthesis Implantation; Injections, Subcutaneous; Postoperative Care; Postoperative Complications; Random Allocation; Risk Factors; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate; Swine; Thromboembolism; Thrombolytic Therapy; Ticlopidine; Time Factors | 2008 |
Acute myocardial infarction in pregnancy.
Topics: Adult; Angioplasty, Balloon, Coronary; Anticoagulants; Apgar Score; Aspirin; Cesarean Section; Coronary Angiography; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Female; Humans; Infant, Newborn; Metoprolol; Myocardial Infarction; Parity; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Cardiovascular; Sympatholytics; Time Factors; Treatment Outcome | 2008 |
[Massive retroperitoneal hematoma during enoxaparin combined with aspirin treatment of acute pulmonary embolism: a case report].
Topics: Aged; Aspirin; Enoxaparin; Female; Hematoma; Humans; Pulmonary Embolism; Retroperitoneal Space | 2008 |
Efficacy and safety of optimized antithrombotic therapy with aspirin, clopidogrel and enoxaparin in patients with non-ST segment elevation acute coronary syndromes in clinical practice.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Drug Evaluation; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Hospital Mortality; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Ticlopidine; Treatment Outcome | 2009 |
Paget-Schroetter syndrome forerunning the diagnoses of thoracic outlet syndrome and thrombophilia.
Topics: Activated Protein C Resistance; Anticoagulants; Aspirin; Enoxaparin; Factor V; Heterozygote; Humans; Magnetic Resonance Angiography; Male; Methylenetetrahydrofolate Reductase (NADPH2); Occupational Diseases; Subclavian Vein; Thoracic Outlet Syndrome; Thrombophilia; Upper Extremity Deep Vein Thrombosis; Warfarin; Wrestling; Young Adult | 2010 |
[Unusual reason for unilateral (corrected) Raynaud's phenomenon with intensification when the arms are elevated].
Topics: Adult; Aneurysm; Anticoagulants; Aspirin; Cervical Rib Syndrome; Diagnosis, Differential; Enoxaparin; Female; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Platelet Aggregation Inhibitors; Raynaud Disease; Ribs; Subclavian Artery; Thromboembolism; Urokinase-Type Plasminogen Activator | 2009 |
[Postoperative ischemic acute stroke and thrombolytic therapy].
Topics: Acute Disease; Aged; Anticoagulants; Aphasia, Broca; Aspirin; Cholesteatoma; Ear Diseases; Ear, External; Enoxaparin; Erythrocyte Transfusion; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Lymph Node Excision; Magnetic Resonance Angiography; Postoperative Complications; Postoperative Hemorrhage; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator | 2009 |
Aortic thrombosis in infancy.
Topics: Anticoagulants; Aortic Diseases; Aspirin; Echocardiography, Doppler; Enoxaparin; Female; Humans; Infant; Smoking; Substance-Related Disorders; Thrombosis | 2009 |
New observations in postpartum ovarian vein thrombosis: experience of single center.
Topics: Adult; Anticoagulants; Aspirin; Cesarean Section; Early Diagnosis; Enoxaparin; Female; Humans; Incidence; Israel; Odds Ratio; Ovary; Postoperative Complications; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Pregnancy, Multiple; Prospective Studies; Puerperal Disorders; Risk Factors; Thrombophilia; Venous Thrombosis | 2010 |
The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model.
Topics: Analysis of Variance; Animals; Anticoagulants; Aspirin; Disease Models, Animal; Enoxaparin; Female; Hemorrhage; Hemostasis; Hemostatics; Lacerations; Male; Plant Extracts; Rats; Rats, Wistar | 2009 |
Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enoxaparin; Female; Humans; Pregnancy; Pregnancy Complications; Retrospective Studies | 2009 |
Clinical images: Spontaneous rectus sheath hematoma.
Topics: Aged; Anticoagulants; Aspirin; Enoxaparin; Erythrocyte Transfusion; Female; Fluid Therapy; Hematoma; Humans; Rectus Abdominis; Tomography, X-Ray Computed | 2010 |
[Abdominal tumor after persistent coughing and uncontrolled anticoagulation].
Topics: Abdomen, Acute; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Colonic Pseudo-Obstruction; Comorbidity; Cough; Dalteparin; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hematoma; Humans; Intracranial Embolism; Phenprocoumon; Rectus Abdominis; Ticlopidine | 2010 |
Atypical presentation of an epidural hematoma in a patient receiving aspirin and low molecular weight heparin. Was epidural analgesia the right choice?
Topics: Aged, 80 and over; Analgesia, Patient-Controlled; Aspirin; Enoxaparin; Female; Hematoma, Epidural, Spinal; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Postoperative Care; Treatment Outcome | 2009 |
Calcinosis cutis universalis with pediatric systemic lupus erythematosus.
Topics: Administration, Oral; Antiphospholipid Syndrome; Aspirin; Calcinosis; Child; Cyclosporine; Dermatologic Agents; Diltiazem; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Skin Ulcer; Treatment Outcome | 2010 |
Frequency of bleeding following invasive dental procedures in patients on low-molecular-weight heparin therapy.
Topics: Adolescent; Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Enoxaparin; Female; Gelatin Sponge, Absorbable; Hemostatic Techniques; Hemostatics; Humans; Male; Middle Aged; Oral Hemorrhage; Oral Surgical Procedures; Plasma; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Sutures; Thrombin; Tooth Extraction; Venous Thrombosis; Vitamin K; Warfarin; Young Adult | 2010 |
Antithrombotic therapy for recurrent miscarriage?
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Humans; Nadroparin; Platelet Aggregation Inhibitors; Pregnancy; Treatment Failure | 2010 |
[Addition of antithrombosis in situ in the case of digital replantation: preliminary prospective study of 13 cases].
Topics: Adolescent; Adult; Aged; Amputation, Traumatic; Anastomosis, Surgical; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Finger Injuries; Humans; Lysine; Male; Microsurgery; Middle Aged; Plastic Surgery Procedures; Platelet Aggregation Inhibitors; Prospective Studies; Pyrrolidines; Replantation; Therapeutic Irrigation; Treatment Outcome; Urokinase-Type Plasminogen Activator; Vasodilator Agents | 2010 |
Conservative treatment of spontaneous dissection of multiple coronary arteries.
Topics: Adult; Anti-Arrhythmia Agents; Anticoagulants; Aortic Dissection; Aspirin; Clopidogrel; Coronary Aneurysm; Drug Therapy, Combination; Enoxaparin; Female; Humans; Metoprolol; Platelet Aggregation Inhibitors; Ticlopidine | 2010 |
Effect of enoxaparin and aspirin on hemodynamic disturbances after global cerebral ischemia in rats.
Topics: Animals; Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Circulation; Enoxaparin; Hemodynamics; Laser-Doppler Flowmetry; Male; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Prothrombin Time; Rats; Rats, Sprague-Dawley | 2010 |
Acute myocardial infarction and renal infarction in a bodybuilder using anabolic steroids.
Topics: Adult; Anabolic Agents; Angiography; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Angiography; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Humans; Infarction; Kidney; Male; Methenolone; Myocardial Infarction; Oxymetholone; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine; Tomography, X-Ray Computed; Ultrasonography; Weight Lifting | 2010 |
Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arrhythmias, Cardiac; Aspirin; Cardiac Resynchronization Therapy Devices; Defibrillators, Implantable; Drug Therapy, Combination; Enoxaparin; Female; Hematoma; Humans; Length of Stay; Male; Middle Aged; Multivariate Analysis; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Prospective Studies; Pyridines; Reoperation; Retrospective Studies; Risk Factors | 2011 |
Slow and steady. Reducing thrombotic events in renal transplant recipients treated with IVIg for antibody-mediated rejection.
Topics: Anticoagulants; Aspirin; Enoxaparin; Female; Graft Rejection; Humans; Immunoglobulins, Intravenous; Infusions, Intravenous; Kidney Transplantation; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombosis | 2011 |
Low-molecular-weight heparin in atherosclerotic stroke: a surprising resurrection of anticoagulants?
Topics: Antifibrinolytic Agents; Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Female; Humans; Intracranial Arterial Diseases; Male; Nadroparin; Platelet Aggregation Inhibitors; Stroke | 2012 |
Inpatient enoxaparin and outpatient aspirin chemoprophylaxis regimen after primary hip and knee arthroplasty: a preliminary study.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Body Mass Index; Enoxaparin; Female; Humans; Inpatients; Length of Stay; Male; Middle Aged; Outpatients; Postoperative Complications; Pulmonary Embolism; Retrospective Studies; Venous Thrombosis | 2012 |
Postoperative anticoagulation in patients with mechanical heart valves following surgical treatment of subdural hematomas.
Topics: Aged; Anticoagulants; Aspirin; Enoxaparin; Female; Follow-Up Studies; Heart Valve Prosthesis Implantation; Hematoma, Subdural; Humans; Male; Middle Aged; Morbidity; Patient Discharge; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Factors; Thromboembolism; Warfarin | 2013 |
Extensive skin necrosis induced by low-molecular-weight heparin in a patient with systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Drug Eruptions; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Glucocorticoids; Humans; Hysterectomy; Lupus Erythematosus, Systemic; Middle Aged; Necrosis; Prednisone; Skin; Thrombosis | 2012 |
Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty.
Topics: Adult; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Dalteparin; Female; Humans; Male; Retrospective Studies; Risk; Thromboembolism; Tranexamic Acid; Warfarin | 2013 |
Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chemoprevention; Clopidogrel; Enoxaparin; Humans; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Risk; Ticlopidine; Warfarin | 2012 |
Thromboprophylaxis prescribing and thrombotic event rates in multiple myeloma patients treated with lenalidomide or thalidomide at a specialist cancer hospital.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticoagulants; Aspirin; Cancer Care Facilities; Enoxaparin; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Incidence; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Practice Patterns, Physicians'; Prognosis; Retrospective Studies; Specialization; Thalidomide; Thrombosis; Warfarin | 2013 |
Abciximab for distal thromboaspiration catheter-related embolization in ST-segment elevated myocardial infarction.
Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Aspirin; Combined Modality Therapy; Coronary Angiography; Coronary Thrombosis; Coronary Vessels; Electrocardiography; Embolism; Enoxaparin; Female; Humans; Immunoglobulin Fab Fragments; Infusions, Parenteral; Injections, Intra-Arterial; Middle Aged; Myocardial Infarction; Piperazines; Prasugrel Hydrochloride; Stents; Suction; Thiophenes; Thrombectomy | 2012 |
Safety of peri-operative low-dose aspirin as a part of multimodal venous thromboembolic prophylaxis for total knee and hip arthroplasty.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Combined Modality Therapy; Enoxaparin; Female; Humans; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Platelet Aggregation Inhibitors; Stockings, Compression; Ultrasonography, Doppler, Duplex; Venous Thrombosis | 2012 |
Acute myocardial infarction and heart block: a challenge to emergency physicians.
Topics: Aspirin; Clopidogrel; Electrocardiography; Enoxaparin; Fibrinolytic Agents; Heart Block; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Ticlopidine | 2013 |
Safety and efficacy of intense antithrombotic treatment and percutaneous coronary intervention deferral in patients with large intracoronary thrombus.
Topics: Acute Coronary Syndrome; Angiography; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Coronary Thrombosis; Enoxaparin; Humans; Inpatients; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Thrombectomy; Thrombolytic Therapy; Ticlopidine | 2013 |
Low molecular weight heparin in patients undergoing free tissue transfer following head and neck ablative surgery: review of efficacy and associated complications.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Dalteparin; Dose-Response Relationship, Drug; Factor Xa; Female; Free Tissue Flaps; Head and Neck Neoplasms; Hematoma; Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk; Treatment Outcome | 2013 |
Effect of acetylsalicylic acid on microvascular thrombosis in autologous breast reconstruction.
Topics: Adult; Aspirin; Autografts; Fibrinolytic Agents; Humans; Mammaplasty; Middle Aged; Myocutaneous Flap; Nadroparin; Surgical Flaps; Thrombosis; Vascular Patency | 2014 |
Aspirin after dalteparin was noninferior to continued dalteparin for preventing VTE after total hip arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Dalteparin; Female; Humans; Male; Platelet Aggregation Inhibitors; Venous Thromboembolism | 2013 |
Aspirin versus low-molecular-weight heparin after total hip arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Dalteparin; Female; Humans; Male; Platelet Aggregation Inhibitors; Venous Thromboembolism | 2013 |
Aspirin versus low-molecular-weight heparin after total hip arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Dalteparin; Female; Humans; Male; Platelet Aggregation Inhibitors; Venous Thromboembolism | 2013 |
[Thrombosis prophylaxis after hip surgery- aspirin is not inferior to heparin].
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Dalteparin; Female; Humans; Male; Platelet Aggregation Inhibitors; Venous Thromboembolism | 2013 |
[Bullous hemorrhagic dermatosis induced by heparin: description of 2 new cases].
Topics: Aged; Anticoagulants; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Drug Eruptions; Enoxaparin; Hemorrhage; Humans; Male; Skin Diseases, Vesiculobullous; Thrombocytopenia | 2014 |
Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2014 |
Hypoxia and the anticoagulants dalteparin and acetylsalicylic acid affect human placental amino acid transport.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Transport System A; Amino Acid Transport System L; Anticoagulants; Aspirin; Biological Transport; Carbon Radioisotopes; Chorionic Villi; Dalteparin; Female; Humans; Hypoxia; In Vitro Techniques; Phosphorylation; Placenta; Pregnancy; Regulatory-Associated Protein of mTOR; Signal Transduction; STAT3 Transcription Factor; Tritium | 2014 |
Restoration of ovarian function and natural fertility following the cryopreservation and autotransplantation of whole adult sheep ovaries.
Topics: Animals; Anti-Mullerian Hormone; Anticoagulants; Aspirin; Cryopreservation; Drug Therapy, Combination; Enoxaparin; Female; Fertility; Fertility Preservation; Gonadotropins; Ovarian Follicle; Ovary; Pregnancy; Pregnancy Rate; Progesterone; Sheep; Tissue Preservation; Transplantation, Autologous | 2014 |
Anticoagulation management of left ventricular assist devices.
Topics: Anticoagulants; Aspirin; Enoxaparin; Female; Heart Failure; Heart Transplantation; Heart Ventricles; Heart-Assist Devices; Humans; Middle Aged; Thrombosis; Treatment Outcome; Warfarin | 2015 |
Transient homonymous hemianopia caused by cerebral venous sinus thrombosis: case report.
Topics: Anticoagulants; Aspirin; Cerebral Veins; Enoxaparin; Female; Hemianopsia; Humans; Magnetic Resonance Imaging; Sinus Thrombosis, Intracranial; Visual Field Tests; Visual Fields; Warfarin; Young Adult | 2014 |
Partial segmental thrombosis of the corpus cavernosum (PSTCC) diagnosed by contrast-enhanced ultrasound: a case report.
Topics: Adult; Anticoagulants; Aspirin; Contrast Media; Edema; Enoxaparin; Humans; Male; Pain; Penile Diseases; Perineum; Thrombosis; Ultrasonography; Young Adult | 2014 |
Investigation of possible prophylactic, renoprotective, and cardioprotective effects of thromboprophylactic drugs against ischemia-reperfusion injury.
Topics: Animals; Anticoagulants; Aryldialkylphosphatase; Aspirin; Cardiotonic Agents; Clopidogrel; Dipeptidases; Drug Evaluation, Preclinical; Enoxaparin; Femoral Artery; Heparin, Low-Molecular-Weight; Hindlimb; Kidney; Male; Malondialdehyde; Morpholines; Myocardium; Nitric Oxide; Oxidative Stress; Rats, Sprague-Dawley; Reperfusion Injury; Rivaroxaban; Thiophenes; Ticlopidine | 2015 |
Cardioembolic acute myocardial infarction associated with apical ballooning: Considerations.
Topics: Aged, 80 and over; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Echocardiography; Electrocardiography; Enoxaparin; Female; Humans; Myocardial Infarction; Takotsubo Cardiomyopathy; Ticlopidine | 2015 |
Perioperative Management of Antiplatelets and Anticoagulants Among Patients Undergoing Elective Transurethral Resection of the Prostate--A Single Institution Experience.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Elective Surgical Procedures; Enoxaparin; Hemorrhage; Humans; Male; Middle Aged; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Prostate; Prostatic Hyperplasia; Retrospective Studies; Thromboembolism; Ticlopidine; Transurethral Resection of Prostate; Victoria; Warfarin; Withholding Treatment | 2015 |
[Acute unilateral arteritic anterior ischemic optic neuropathy becoming bilateral despite corticosteroid therapy].
Topics: Acute Disease; Aged; Alzheimer Disease; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Disease Progression; Drug Resistance; Emergencies; Enoxaparin; Female; Giant Cell Arteritis; Headache; Humans; Methylprednisolone; Optic Neuropathy, Ischemic; Papilledema; Platelet Aggregation Inhibitors | 2016 |
Clinical Performance of the 1st American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism after Total Knee Arthroplasty in Korean Patients.
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Cohort Studies; Enoxaparin; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Orthopedics; Postoperative Complications; Postoperative Hemorrhage; Practice Guidelines as Topic; Pulmonary Embolism; Republic of Korea; Retrospective Studies; Risk Factors; Societies, Medical; Stockings, Compression; Venous Thrombosis | 2015 |
Presumed bilateral cilioretinal artery occlusion related to relapsing white dot syndrome.
Topics: Arterial Occlusive Diseases; Aspirin; Ciliary Arteries; Coloring Agents; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Methylprednisolone; Papilledema; Recurrence; Retinal Artery Occlusion; Retinal Diseases; Tomography, Optical Coherence; Vision Disorders; Visual Acuity; Young Adult | 2016 |
Partial thrombosis of the corpus cavernosum: should we dig deeper into coagulopathy disorders?
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Factor V; Humans; Magnetic Resonance Imaging; Male; Priapism; Thrombosis; Treatment Outcome; Ultrasonography; Young Adult | 2016 |
Letter to the Editor on "Rate of Transfusions Following Total Knee Arthroplasty in Patients Receiving Lovenox or High Dose Aspirin".
Topics: Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Heparin, Low-Molecular-Weight; Humans; Venous Thromboembolism | 2016 |
To anticoagulate? Controversy in the management of thrombotic complications of head & neck infections.
Topics: Adolescent; Anticoagulants; Aspirin; Cavernous Sinus Thrombosis; Cerebral Angiography; Child; Child, Preschool; Cohort Studies; Computed Tomography Angiography; Disease Management; Enoxaparin; Female; Fusobacterium Infections; Heparin, Low-Molecular-Weight; Humans; Infant; Lemierre Syndrome; Magnetic Resonance Angiography; Male; Mastoiditis; Peritonsillar Abscess; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Retropharyngeal Abscess; Retrospective Studies; Sinusitis; Tinzaparin; Venous Thrombosis | 2016 |
Antithrombotic Medication Use and Misuse Among Patients with Intracranial Hemorrhage: A 16-Year, Lebanese, Single-Center Experience.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Clopidogrel; Coronary Artery Disease; Enoxaparin; Female; Fibrinolytic Agents; Humans; Inappropriate Prescribing; Intracranial Hemorrhages; Lebanon; Male; Middle Aged; Platelet Aggregation Inhibitors; Prescription Drug Misuse; Retrospective Studies; Risk Factors; Stroke; Ticlopidine; Warfarin; Young Adult | 2016 |
Rate of Transfusions After Total Knee Arthroplasty in Patients Receiving Lovenox or High-Dose Aspirin.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Blood Transfusion; Enoxaparin; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Pulmonary Embolism; Retrospective Studies; Venous Thromboembolism; Venous Thrombosis | 2016 |
Repeated Thrombosis After Synthetic Cannabinoid Use.
Topics: Adult; Anticoagulants; Aspirin; Cannabinoids; Enoxaparin; Female; Humans; Infarction; Platelet Aggregation Inhibitors; Pregnancy; Pulmonary Embolism; Risk Factors; Stroke; Substance-Related Disorders; Thromboembolism; Tomography, X-Ray Computed; Warfarin | 2016 |
Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial.
Topics: Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Placenta; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications | 2017 |
Recurrent Massive Perivillous Fibrin Deposition and Chronic Intervillositis Treated With Heparin and Intravenous Immunoglobulin: A Case Report.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Anticoagulants; Aspirin; Chorionic Villi; Dalteparin; Female; Fetal Growth Retardation; Fibrin; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Placenta; Placenta Diseases; Platelet Aggregation Inhibitors; Pregnancy | 2017 |
Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM)
Topics: Aged; Aspirin; Catheterization, Peripheral; Clopidogrel; Coronary Angiography; Enoxaparin; Female; Femoral Artery; Fibrinolytic Agents; Heart Failure; Hemorrhage; Humans; Male; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Radial Artery; Recurrence; Shock; ST Elevation Myocardial Infarction; Tenecteplase; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator | 2016 |
Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Cohort Studies; Databases, Factual; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Postoperative Hemorrhage; Pulmonary Embolism; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2017 |
Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Cohort Studies; Enoxaparin; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Polysaccharides; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2017 |
CORR Insights
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Factor Xa Inhibitors; Humans; Thromboembolism; Venous Thromboembolism; Warfarin | 2017 |
Conservative treatment of patients with thromboangiitis obliterans or cannabis-associated arteritis presenting with critical lower limb ischaemia.
Topics: Adult; Amputation, Surgical; Ankle Brachial Index; Anticoagulants; Arteritis; Aspirin; Cardiovascular Agents; Cilostazol; Critical Illness; Drug Therapy, Combination; Female; Heparin, Low-Molecular-Weight; Humans; Iloprost; Infusions, Intravenous; Ischemia; Limb Salvage; Lower Extremity; Male; Marijuana Abuse; Marijuana Smoking; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Smoking; Smoking Cessation; Tetrazoles; Thromboangiitis Obliterans; Time Factors; Treatment Outcome; Vasodilator Agents | 2017 |
Wound Discharge After Pharmacological Thromboprophylaxis in Lower Limb Arthroplasty.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Elective Surgical Procedures; Enoxaparin; Female; Heparin, Low-Molecular-Weight; Humans; Lower Extremity; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Thromboembolism; Venous Thrombosis | 2018 |
Effects of aspirin and enoxaparin in a rat model of liver fibrosis.
Topics: Animals; Antithrombins; Aspirin; Disease Models, Animal; Enoxaparin; Liver; Liver Cirrhosis, Experimental; Liver Function Tests; Male; Rats; Rats, Sprague-Dawley; Thioacetamide | 2017 |
Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Dalteparin; Equipment Design; Female; Fibrinolytic Agents; Hemostatic Techniques; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Patient Readmission; Postoperative Hemorrhage; Pressure; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Venous Thromboembolism; Wound Healing | 2018 |
Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban, Enoxaparin, or Aspirin for Thromboprophylaxis.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Blood Loss, Surgical; Enoxaparin; Female; Humans; Male; Middle Aged; Retrospective Studies; Rivaroxaban; Thrombosis | 2018 |
Vascular endothelial growth factor and soluble vascular endothelial growth factor receptor-1 in patients with end-stage renal disease. Associations with laboratory findings, comorbidities, and medications.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aspirin; Calcium Channel Blockers; Cardiovascular Diseases; Comorbidity; Cross-Sectional Studies; Enoxaparin; Erythropoietin; Female; Fibrinolytic Agents; Humans; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2018 |
Differences in Reported Outcomes in Industry-Funded vs Nonfunded Studies Assessing Thromboprophylaxis After Total Joint Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Conflict of Interest; Dabigatran; Enoxaparin; Female; Fondaparinux; Health Care Sector; Hemorrhage; Humans; Male; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Venous Thromboembolism; Warfarin | 2018 |
Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clinical Decision-Making; Dabigatran; Databases, Factual; Enoxaparin; Female; Fondaparinux; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Rivaroxaban; Venous Thrombosis; Warfarin | 2018 |
Aspirin Alone Is Not Enough to Prevent Deep Venous Thrombosis After Total Joint Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; Drug Therapy, Combination; Enoxaparin; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Venous Thrombosis; Warfarin | 2019 |
Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Databases, Factual; Enoxaparin; Female; Fondaparinux; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Orthopedic Procedures; Orthopedics; Practice Patterns, Physicians'; Risk Factors; Rivaroxaban; United States; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2019 |
Venous thromboprophylaxis after total hip arthroplasty: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2020 |
Enoxaparin (or plus aspirin) for the prevention of recurrent miscarriage: a meta-analysis of randomized controlled studies.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Pregnancy; Prospective Studies; Version, Fetal | 2019 |
The Role of Chemoprophylactic Agents in Modulating Platelet Aggregability After Traumatic Brain Injury.
Topics: Amitriptyline; Animals; Aspirin; Blood Coagulation; Brain Injuries, Traumatic; Disease Models, Animal; Enoxaparin; Humans; Lipid Metabolism; Male; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Sphingolipids; Thrombelastography; Venous Thromboembolism | 2019 |
Aspirin as venous thromboembolic event prophylaxis post total hip and knee arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Humans; Venous Thromboembolism | 2019 |
Comparison of the Efficacy and Safety of Aspirin and Rivaroxaban Following Enoxaparin Treatment for Prevention of Venous Thromboembolism after Hip Fracture Surgery.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Female; Hip Fractures; Humans; Male; Middle Aged; Postoperative Complications; Postoperative Period; Retrospective Studies; Rivaroxaban; Venous Thromboembolism | 2019 |
Frostbite of the hands after paragliding: a chilling experience.
Topics: Aspirin; Athletic Injuries; Betamethasone; Drug Therapy, Combination; Enoxaparin; Frostbite; Hand Injuries; Humans; Iloprost; Male; Treatment Outcome | 2019 |
Prophylaxis for Pediatric Venous Thromboembolism: Current Status and Changes Across Pediatric Orthopaedic Society of North America From 2011.
Topics: Aspirin; Enoxaparin; Guideline Adherence; Humans; North America; Orthopedic Procedures; Pediatrics; Postoperative Complications; Practice Patterns, Physicians'; Pulmonary Embolism; Stockings, Compression; Surveys and Questionnaires; Venous Thromboembolism | 2020 |
Safety and Pharmacokinetics of DS-1040 Drug-Drug Interactions With Aspirin, Clopidogrel, and Enoxaparin.
Topics: Administration, Oral; Adult; Area Under Curve; Aspirin; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clopidogrel; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Healthy Volunteers; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Venous Thromboembolism; Young Adult | 2020 |
Primary prophylaxis of venous thromboembolism in extragonadal germ-cell tumour.
Topics: Anticoagulants; Antineoplastic Agents; Aspirin; Cisplatin; Enoxaparin; Hemorrhage; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Primary Prevention; Risk Assessment; Risk Factors; Treatment Outcome; Venous Thromboembolism | 2020 |
Aspirin compared to enoxaparin or rivaroxaban for thromboprophylaxis following hip and knee replacement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Delayed-Action Preparations; Elective Surgical Procedures; Enoxaparin; Female; Humans; Ireland; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk Factors; Rivaroxaban; Socioeconomic Factors; Venous Thromboembolism; Young Adult | 2020 |
Cerebral Infarction in an Elderly Patient with Coronavirus Disease.
Topics: Aged, 80 and over; Anticoagulants; Aspirin; Betacoronavirus; Cerebral Infarction; Coronavirus; Coronavirus Infections; Cough; COVID-19; Diffusion Magnetic Resonance Imaging; Enoxaparin; Humans; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Thorax; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Potential drug-drug interactions in ICU patients: a retrospective study.
Topics: Aspirin; Diabetes Mellitus; Drug Interactions; Enoxaparin; Hospitalization; Humans; Hypertension; Intensive Care Units; Myocardial Ischemia; Retrospective Studies | 2020 |
A Rare Finding of Upper Limb Deep Venous Thrombosis in a Patient with COVID-19.
Topics: Anticoagulants; Arm; Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Edema; Enoxaparin; Humans; Jugular Veins; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome; Ultrasonography, Doppler; Venous Thrombosis | 2020 |
Image and clinical analysis of common carotid web: a case report.
Topics: Aged; Anticoagulants; Aspirin; Basal Ganglia Diseases; Carotid Artery Diseases; Carotid Artery, Common; Cerebral Infarction; Clopidogrel; Computed Tomography Angiography; Diagnosis, Differential; Enoxaparin; Humans; Magnetic Resonance Imaging; Male; Platelet Aggregation Inhibitors | 2021 |
NETosis Markers in Pregnancy: Effects Differ According to Histone Subtypes.
Topics: Adult; Apoptosis; Aspirin; Cell Line; Cell Movement; Enoxaparin; Extracellular Traps; Female; France; Heparin, Low-Molecular-Weight; Histones; Humans; Kinetics; Neutrophils; Nucleosomes; Pilot Projects; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Prospective Studies; Trophoblasts; Young Adult | 2021 |
57-Year-Old Woman With Weakness and Word-Finding Difficulties.
Topics: Adenocarcinoma, Clear Cell; Antibodies, Antiphospholipid; Aspirin; Biomarkers, Tumor; Cerebral Infarction; Cognitive Dysfunction; Enoxaparin; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Muscle Weakness; Ovarian Neoplasms; Palliative Care; Secondary Prevention | 2021 |
Analysis of blood clotting with the total thrombus analysis system in healthy dogs.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Blood Coagulation Tests; Dalteparin; Dogs; Female; Male; Microfluidic Analytical Techniques; Thrombosis | 2021 |
A retrospective analysis of bleeding risk with rivaroxaban, enoxaparin, and aspirin following total joint arthroplasty or revision.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Humans; Postoperative Hemorrhage; Reoperation; Retrospective Studies; Risk Assessment; Rivaroxaban; Venous Thromboembolism | 2021 |
Acetylsalicylic Acid Compared with Enoxaparin for the Prevention of Thrombosis and Mechanical Ventilation in COVID-19 Patients: A Retrospective Cohort Study.
Topics: Anticoagulants; Aspirin; COVID-19; Enoxaparin; Humans; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Thrombosis | 2021 |
Cost-Effectiveness of Aspirin for Extended Venous Thromboembolism Prophylaxis After Major Surgery for Inflammatory Bowel Disease.
Topics: Aftercare; Anticoagulants; Aspirin; Cost-Benefit Analysis; Enoxaparin; Humans; Inflammatory Bowel Diseases; Patient Discharge; Venous Thromboembolism | 2022 |
Coexistence of SARS-CoV-2 and cerebrovascular diseases: does COVID-19 positivity trigger cerebrovascular pathologies?
Topics: Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clopidogrel; COVID-19; Enoxaparin; Humans; Mannitol; Nervous System Diseases; Piracetam; Pyrazoles; Pyridones; Retrospective Studies; SARS-CoV-2 | 2022 |
Does Aspirin Provide Adequate Chemoprophylaxis for Venous Thromboembolic Events in Operative Pelvic and Acetabular Fractures?
Topics: Anticoagulants; Aspirin; Chemoprevention; Enoxaparin; Hematoma; Heparin; Hip Fractures; Humans; Pelvis; Pulmonary Embolism; Retrospective Studies; Spinal Fractures; Venous Thromboembolism; Venous Thrombosis | 2022 |
Cost-Effective Modeling of Thromboembolic Chemoprophylaxis for Total Ankle Arthroplasty.
Topics: Ankle; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; Cost-Benefit Analysis; Enoxaparin; Humans; Postoperative Complications; Rivaroxaban; Venous Thromboembolism; Warfarin | 2022 |
In THA or TKA, risk for symptomatic VTE was higher with aspirin vs. enoxaparin at 90 d.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Humans; Randomized Controlled Trials as Topic; Venous Thromboembolism | 2022 |
Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty-Reply.
Topics: Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Humans; Postoperative Complications; Venous Thromboembolism | 2023 |
Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Humans; Postoperative Complications; Venous Thromboembolism | 2023 |
Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Humans; Postoperative Complications; Venous Thromboembolism | 2023 |
Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Humans; Postoperative Complications; Venous Thromboembolism | 2023 |
Post-discharge patient-reported non-adherence to aspirin compared to enoxaparin for venous thromboembolism prophylaxis after hip or knee arthroplasty.
Topics: Aftercare; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Humans; Patient Discharge; Patient Reported Outcome Measures; Venous Thromboembolism | 2023 |
Detection and analysis of potential drug-drug interactions among patients admitted to the cardiac care unit in a tertiary care hospital.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Enoxaparin; Furosemide; Humans; Lisinopril; Ranitidine; Tertiary Care Centers | 2023 |
Enoxaparin Is Better Than Aspirin for the Prevention of Venous Thromboembolism After Total Hip or Knee Arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Humans; Postoperative Complications; Venous Thromboembolism | 2023 |
Safety and Efficacy of Rivaroxaban in Primary Total Hip and Knee Arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Hemorrhage; Humans; Rivaroxaban; Venous Thromboembolism | 2023 |
Hemostatics in patients with inhibited coagulation-A viscoelastic in-vitro analysis.
Topics: Anticoagulants; Aspirin; Enoxaparin; Hemostatics; Heparin; Humans; Phenprocoumon | 2023 |
In limb or pelvic fracture, aspirin was noninferior to enoxaparin for reducing all-cause death.
Topics: Anticoagulants; Aspirin; Enoxaparin; Extremities; Fractures, Bone; Humans; Venous Thromboembolism | 2023 |
Twice-Daily Low-Dose Aspirin Is Similar to Enoxaparin for Thromboprophylaxis After Inpatient Treatment for Fracture.
Topics: Anticoagulants; Aspirin; Enoxaparin; Fractures, Bone; Humans; Inpatients; Venous Thromboembolism | 2023 |
Combination of enoxaparin and low-dose aspirin for thromboprophylaxis in selective patients after primary total joint arthroplasty in a Taiwanese population.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Enoxaparin; Humans; Postoperative Complications; Pulmonary Embolism; Retrospective Studies; Venous Thromboembolism; Venous Thrombosis | 2023 |
Is low-molecular-weight heparin superior to aspirin for VTE prophylaxis?
Topics: Anticoagulants; Aspirin; Enoxaparin; Heparin; Heparin, Low-Molecular-Weight; Humans; Venous Thromboembolism | 2023 |